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EXECUTIVE SUMMARY 
 
Cancer Incidence and Mortality in Massachusetts, 2011-2015: Statewide Report presents cancer 
incidence and mortality data for the Commonwealth from 2011 through 2015. The report includes 
numbers and rates for 24 types of cancer, information on age-specific patterns, an examination of 
patterns by race/ethnicity, and a comparison of Massachusetts and national cancer rates. A special 
section on Environmental Public Health Tracking and Radon is also included.  Data are provided 
on invasive cancers only with the exceptions of urinary bladder (which includes in situ and 
invasive cancers combined) and in situ breast cancer.  In situ means the cancer cells are still in the 
place that they started and have not spread at all.   
 
All counts and average annual age-adjusted rates presented in this Executive Summary are 
for the period 2011-2015 and are for Massachusetts residents, unless otherwise stated.   
 
OVERALL: 
 
 Total number of new cases – 183,661, an average of  36,732 annually (males= 87,884;  
females = 95,757) 
 Total number of cancer deaths –  64,097, an average of  12,819 annually (males=32,392; 
females=31,705) 
 Incidence rate (age-adjusted) for all cancers combined for total population – 466.1 per 
100,000 persons 
 Mortality rate (age-adjusted) for all cancer deaths combined for total population – 156.1 
per 100,000 persons. 
 
MOST COMMONLY DIAGNOSED CANCERS & CANCER DEATH CAUSES BY SEX: 
 
Incidence (newly diagnosed cases) 
 Males – prostate cancer accounted for 23.2% of all newly diagnosed cancers among males 
 Females – invasive breast cancer accounted for 30.0% of all newly diagnosed cancers 
among females. 
 
Mortality (cancer deaths) 
 Males – cancer of the bronchus and lung accounted for 26.3% of all cancer deaths among 
males 
 Females – cancer of the bronchus and lung also accounted for 27.1% of all cancer deaths 
among females.  
 
TRENDS 2011-2015: 
 
Trend Calculation Update:  The annual percent change (APC) is a summary measure of the trend 
over a specific time period.  As of this report, we will be using the coefficient of variation (CV) to 
determine which APC rates to suppress and which to flag as being unreliable.  The CV is 
calculated by dividing the mean incidence or mortality age-adjusted rate for each of the five years 
by the standard error and multiplying that by 100.  According to the US Census, a CV less than 
15% indicates a high reliability and can presented without caution, a CV between 
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15‐30% indicates a medium reliability and can be presented with care, and a CV over 
30% indicates a low reliability and can only be presented with extreme caution (footnote).  This 
report presents all trends with a high reliability and all trends with a medium reliability with a 
footnote.  Any trends with a low reliability are not presented and are indicated with ‘NA’. 
 
Footnote- Barbara M. Parmenter and Janet Lau, ‘Estimating and Mapping Reliability for American 
Community Survey Data’, revised 2/14/2013, available: http://ocw.tufts.edu/data/74/1624027.pdf 
 
Statistically Significant Incidence Trends – Males 
 All cancers combined decreased 3.1% per year. 
 Bronchus & lung cancer decreased 2.9% per year. 
 Esophageal cancer decreased 5.2% per year. 
 Hodgkin’s lymphoma decreased 6.3% per year. 
 Kidney and renal pelvis cancer increased  4.1% per year. 
 Melanoma of skin decreased 7.1% per year.  
 Non-Hodgkin’s lymphoma increased 1.5% per year. 
 Testicular cancer decreased by 2.2% per year. 
 
Statistically Significant Mortality Trends – Males 
 All cancers deaths combined decreased 2.4% per year. 
 Bronchus and lung cancer decreased 2.2% per year. 
 Kidney and renal pelvis cancer increased 6.7% per year. 
 
Statistically Significant Incidence Trends – Females 
 All cancers combined decreased 0.7% per year. 
 Multiple myeloma decreased 4.7% per year.  
 Pancreatic cancer increased 3.0% per year. 
 Urinary bladder cancer decreased 3.1% per year. 
 
Statistically Significant Mortality Trends – Females 
 All cancers deaths combined decreased 1.7% per year. 
 Breast cancer deaths decreased 1.5% per year. 
 
RATES BY RACE/ETHNICITY: (Unless otherwise noted, the term ‘racial/ethnic groups’ in this 
report refers to white non-Hispanic, black non-Hispanic, Asian non-Hispanic and Hispanic). 
 
Males Incidence 
 Black, non-Hispanic males had the highest total age-adjusted incidence rates, significantly 
higher than Asian, non-Hispanic and Hispanic males. 
 Cancers of prostate, bronchus and lung, and colon/rectum were the top 3 leading cancer 
types in each racial/ethnic group except White, non Hispanics.  For White, non-Hispanic 
males, urinary bladder cancer was among the top 3, (after prostate and bronchus and lung). 
 White, non-Hispanic males had significantly higher rates of cancers of the brain and other 
nervous system, esophagus, leukemia, oral cavity and pharynx, and urinary bladder when 
compared to all other race/ethnic groups. 
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 Black, non-Hispanic males had significantly higher rates of multiple myeloma and prostate 
cancer when compared to all other race/ethnic groups. 
 Black, non-Hispanic, Asian, non-Hispanic, and Hispanic males had significantly higher 
rates of liver and intrahepatic bile duct cancer when compared to white, non-Hispanic 
males. 
Males Mortality 
 Black, non-Hispanic males had the highest total cancer mortality rate, significantly higher 
compared to Asian, non-Hispanics and Hispanic but not significantly higher than white, 
non-Hispanic males. 
 Cancer of the bronchus and lung was the leading cause of cancer death for each 
racial/ethnic group. White and black, non-Hispanics had comparable rates but significantly 
elevated rates compared to the other two racial/ethnic groups. 
 The mortality rate for prostate cancer was significantly elevated among black, non-
Hispanic males compared to the other racial/ethnic groups.   
 The mortality rate for liver and intrahepatic cancer was highest among Asian, non-
Hispanics, significantly elevated compared to white, non-Hispanics and Hispanics, but not 
compared to black, non-Hispanics. 
 
Females Incidence 
 White, non-Hispanic females had the highest total age-adjusted incidence rates, 
significantly higher than those of all other racial/ethnic groups. 
 Breast cancer was the most commonly diagnosed cancer for each racial/ethnic group. 
 The second most common cancer diagnosed was bronchus and lung for each racial/ethnic 
group except Hispanics.  Thyroid was the second most common cancer for Hispanics, 
followed by bronchus and lung. 
 Compared to all other racial/ethnic groups, white, non-Hispanic females had significantly 
higher rates of the following cancer types:  invasive breast, in situ breast, and bronchus and 
lung. 
 Black, non-Hispanic females had significantly higher rates of multiple myeloma compared 
to all other racial/ethnic groups. 
 Black, non-Hispanic and Hispanic females had significantly higher rates of cervical cancer 
compared to white, non-Hispanic females, but not compared to Asian, non-Hispanic 
females. 
 Asian, non-Hispanic females had significantly higher liver and intrahepatic bile duct cancer 
rates compared to white non-Hispanics and black non-Hispanics, but not compared to 
Hispanics. 
 Hispanic females had significantly higher rates of multiple myeloma compared to white, 
non-Hispanic and Asian, non-Hispanic females, but not compared to Black, non-Hispanic 
females. 
 
Females Mortality 
 Black and white, non-Hispanic females had the highest total cancer mortality rates, 
significantly higher than for Asian, non-Hispanic and Hispanic females. 
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 Cancer of the bronchus and lung was the leading cause of cancer death among all 
racial/ethnic groups. White, non-Hispanic females had significantly elevated rates 
compared to the other racial/ethnic groups. 
 Black, non-Hispanic females had significantly elevated uterine cancer and multiple 
myeloma mortality rates when compared to the other racial/ethnic groups.  Their breast 
cancer mortality rate was significantly elevated compared to that of Asian, non-Hispanic 
and Hispanic females, but was not significantly elevated compared to white, non-Hispanic 
females.  
 
MASSACHUSETTS VS. NATIONAL RATES 
 
Males and Females Incidence 
 
Overall age-adjusted cancer incidence rates in Massachusetts were significantly lower than 
national rates for males, and were significantly higher than national rates for females.  Among the 
cancers significantly elevated for females were invasive and in situ breast, bronchus and lung, 
uterine, esophageal, oral cavity and pharynx, thyroid, and urinary bladder.  Among those cancers 
significantly elevated for males were esophageal, liver and intrahepatic bile ducts, testicular, 
thyroid and urinary bladder.  Incidence rates that were significantly lower compared to the U.S. 
among females were cervix uteri, colon and rectum, leukemia , and liver and intrahepatic bile 
ducts, while among males the cancer types included bronchus and lung, colon and rectum, larynx, 
leukemia, melanoma of skin, and prostate. 
         
Males and Females Mortality 
 
Overall age-adjusted cancer mortality rates in Massachusetts were significantly lower from 
national rates for both males and females.  However, male esophageal cancer mortality rates were 
significantly elevated compared to the U.S.  Several cancers had significantly lower mortality rates 
compared to the U.S. For males, these were colon/rectum, bronchus and lung, kidney and renal 
pelvis, larynx, multiple myeloma, non-Hodgkin lymphoma, and prostate cancer.  For females, 
these were breast, cervix uteri, colon/rectum, kidney and renal pelvis, and liver and intrahepatic 
bile duct cancer.    
 
         
 
 
  
 
 
 
 
 
 
 
 
 
 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7 
 
INTRODUCTION 
 
The Massachusetts Cancer Registry (MCR) collects reports of newly diagnosed cases of cancer and 
routinely compiles summaries of cancer incidence and mortality data. This report, Cancer Incidence and 
Mortality in Massachusetts, 2011-2015: Statewide Report is produced annually with the most recently 
available statewide data. Another report, Cancer Incidence in Massachusetts: City and Town Supplement, is 
also produced annually and contains information for the 351 cities and towns in Massachusetts. Electronic 
versions of these reports may be found on the internet at www.mass.gov/dph/mcr.  
 
Overall Content 
 
This report: 
 
 Provides statewide information on cancer incidence and mortality in Massachusetts for twenty-four 
types of cancer and for all cancers combined for 2011 through 2015;* 
 
 Provides detailed information on the most commonly occurring types of cancer for 2011 through 
2015; 
 
 Examines cancer incidence patterns by age, sex, and race/ethnicity; 
 
 Reviews Massachusetts cancer incidence and mortality trends for 2011 through 2015;  
 
 Compares Massachusetts incidence and mortality data with respective national data; and 
 
 Features a special section on “Using Environmental Public Health Tracking for Radon Awareness 
and Cancer Prevention.” 
 
The report is organized into the following sections: 
 
 SPECIAL OVERVIEW which provides more detailed information on a specific topic of interest 
in Massachusetts.  This report has a special overview of radon awareness and cancer prevention. 
 
 FIGURES & TABLES which present cancer incidence and mortality data for 24 types of cancer 
for 2011-2015. There are 6 figures and 24 tables in this section with breakdowns by sex, 
race/ethnicity, year, age group, state and national comparisons, and cancer type. 
 
 APPENDICES which provide information supplemental to this report, including a listing of codes 
used to prepare the report, information on population and rate changes, and population estimates. 
 
 REFERENCES 
 
*The Massachusetts incidence data in this report include only invasive cancers for 22 of the 24 types of 
cancer. Cancer of the urinary bladder includes both in situ and invasive cases. Cancer of the breast in situ 
is presented as a separate category but is not included in the “all sites combined” data. 
 
Note: For more detailed information on the methods of the Massachusetts Cancer Registry, please refer 
to Cancer Incidence and Mortality in Massachusetts 2006-2010: Statewide Report (1).  For national 
trends, please refer to the Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring 
Survival (2).      
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Using Environmental Public Health Tracking for Radon Awareness and 
Cancer Prevention 
The Massachusetts Environmental Public Health Tracking (EPHT) 
website (www.mass.gov/dph/matracking) hosted by the 
Massachusetts Department of Public Health/Bureau of 
Environmental Health (MDPH/BEH) and funded by the U.S. 
Centers for Disease Control and Prevention (CDC) provides an 
opportunity for the public to look at environmental data and chronic 
disease rates statewide and locally.  
Chronic diseases - such as heart disease, stroke, cancer, and diabetes - are among the most 
prevalent, costly, and preventable of all health problems. With the help of MA EPHT, we can 
reduce the burden of these diseases by using data to: 
 Inform decision makers 
 Develop stronger, evidence-based programs, targeted interventions, and policies 
 Evaluate programs and progress 
 
In support of the goals of the 2017-2021 Massachusetts State Cancer Plan, the MA EPHT website 
provides information on both cancer incidence and radon to fulfill the objectives to:  
1) Reduce exposure to radon by increasing testing in homes, and  
2) Provide access to information on cancer risks from environmental exposures to increase 
awareness and prevention.  
 
Cancer Incidence Data on MA EPHT 
Cancer incidence data is just one of many health datasets that are available on the MA EPHT 
website. Two different types of statistics are presented for many different cancer types and are 
calculated using data from the MCR: 
Direct Age-Adjusted Incidence Rates - These are most appropriate for large, stable study 
populations such as a states or counties. They may be used to compare cancer incidence in 
one relatively large area to another relatively large area (such as one county to another).  
 
Standardized Incidence Ratios (SIRs) - These are most appropriate for small areas, such as 
communities or census tracts within a community. They are used to evaluate whether the 
incidence of cancer within a small area differs from that of the state as a whole. 
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This information may be viewed and downloaded as maps, tables, and charts.  
Radon Information on MA EPHT 
Did you know that radon is the second leading cause of lung cancer in the U.S.? The U.S. 
Environmental Protection Agency (EPA) estimates that over 21,000 lung cancer deaths in the U.S. 
each year are related to radon.  
Radon gas decays into microscopic particles 
that can be inhaled into the lungs. Radon 
particles trapped in the lungs continue to 
breakdown, damaging the lung tissue during 
this decay process. This damage increases the 
risk of developing lung cancer. Among people 
who have never smoked, radon is the leading 
cause of lung cancer. 
Radon also increases the chance of lung cancer in people that smoke. For those who are exposed to 
elevated indoor radon levels, people who smoke have up to 10 times the risk of developing lung 
cancer than people who have never smoked. The MA EPHT website provides information on 
radon as well as a radon risk table and a map of radon zones in Massachusetts.  
How does radon enter homes?  
Radon is a naturally occurring radioactive gas that is odorless, 
colorless, and tasteless. As a gas, radon can move through 
pathways in soil and rock formations. 
Radon can enter homes through: 
 cracks and crevices in the foundation floors and walls 
 floor wall joints 
 penetrations of utility lines and sump holes  
 private water well 
Once inside an enclosed space, such as a home, radon can 
collect. Most radon gas found in a home comes up from the 
ground, so the amount of radon is likely to be greater in the lowest 
levels of the home. Radon levels are usually higher in the winter 
time because, during the heating season, warm air rises and 
escapes. This creates a vacuum in the lowest part of the house that causes the house to draw air, 
including radon, from below the home. Any equipment that exhausts air or requires venting can 
also contribute to the vacuum effect. 
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Testing the air in a home is the only way to know if indoor radon levels are elevated. If you 
test your home in warm weather and get a low result, it is wise to test again during the heating 
season. If you have a private well, you should have your water tested for radon too.  For more 
information, see the resources listed below. 
 
For More Information 
MDPH Resources: 
 Massachusetts Environmental Public Health Tracking (MA EPHT): 
www.mass.gov/dph/matracking 
 
 Massachusetts State Cancer Plan:  www.mass.gov/2017-2021-massachusetts-cancer-plan 
 
 MDPH/BEH Radon Fact Sheet:   
http://www.mass.gov/eohhs/docs/dph/environmental/iaq/radon-fact-sheet-2016.pdf  
 
 Massachusetts Cancer Registry (MCR):  www.mass.gov/dph/mcr  
 
Additional Resources: 
 CDC’s National Environmental Public Health Tracking (EPHT) Program: 
www.cdc.gov/nceh/tracking 
 
 EPA’s Citizen’s Guide to Radon: www.epa.gov/radon/pubs/citguide.html  
 
 EPA’s Home Buyer’s and Seller’s Guide to Radon:  
https://www.epa.gov/radon/home-buyers-and-sellers-guide-radon  
 MassDEP’s Guide to Water Quality Testing for Private Wells: 
http://www.mass.gov/eea/agencies/massdep/water/drinking/protect-your-family-a-guide-to-
water-quality-testing-f.html 
Contact: 
 Bureau of Environmental Health 
Massachusetts Department of Public Health 
www.mass.gov/dph/environmental_health 
Phone: 617-624-5757 | Fax: 617-624-5183 | TTY: 617-624-5286 
DPH-MA-EPHT@state.ma.us  
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 Radon Unit  
Massachusetts Department of Public Health/Bureau of Environmental Health 
www.mass.gov/eohhs/gov/departments/dph/programs/environmental-health/exposure-
topics/iaq/radon/ 
Phone: 1-800-RADON-95 or (800) 723-6695 or (413) 586-7525 ext. 3185 
 
 Tobacco Cessation and Prevention Program  
Massachusetts Department of Public Health  
www.makesmokinghistory.org  
Phone: 1-800-QUIT-NOW or (800) 784-8669 
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Figure 1. 
PERCENTAGE OF CANCER INCIDENT CASES BY CANCER TYPE AND SEX 
Massachusetts, 2011-2015  
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Source: Massachusetts Cancer Registry
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Figure 2. 
INCIDENCE RATES
1
 FOR TEN LEADING CANCER TYPES BY SEX 
Massachusetts,  2011-2015 
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1
Rates are age-adjusted to the 2000 U.S. Standard Population.  NOS – Not Otherwise Specified. 
 Source:  Massachusetts Cancer Registry 
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Figure 3. 
PERCENTAGE OF CANCER DEATHS BY CANCER TYPE AND SEX 
Massachusetts, 2011-2015 
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Figure 4. 
MORTALITY RATES
1
 FOR TEN LEADING CANCER TYPES BY SEX 
Massachusetts, 2011-2015 
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Rates are age-adjusted to the 2000 U.S. Standard Population.  *NOS – Not Otherwise Specified. 
 Source:  Massachusetts Vital Statistics 
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Table 1.  
Massachusetts, 2011-2015 
AGE-SPECIFIC INCIDENCE RATES
1
 AND MEDIAN AGE AT DIAGNOSIS FOR SELECTED CANCER SITES  
MALES 
 
 
1
 per 100,000    
2
 Breast in situ is excluded from ‘All Sites’.  3 Dashes indicate age groups with no incident cases.  Source: Massachusetts Cancer Registry
Cancer Site / Type 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ 
Median 
Age 
All Sites 28.4 13.9 11.9 23.5 38.5 55.1 74.3 98.5 161.1 280.6 552.0 899.5 1342.4 1839.5 2405.9 2665.8 2821.0 2807.7 66 
Brain & Other Nervous 
System 5.2 3.8 2.7 2.8 2.5 4.9 4.1 3.5 4.4 5.9 8.6 11.5 16.5 20.4 27.2 29.5 31.0 21.3 60 
Breast -- 0.1 -- -- -- -- 0.3 0.2 0.6 0.9 1.3 2.1 3.3 5.0 7.8 5.9 11.0 8.5 68 
Breast in situ2  -- -- -- -- -- -- -- 0.1 0.2 0.1 0.2 0.3 0.3 0.4 1.0 1.4 0.4 0.8 68 
Bronchus & Lung 0.1   0.1 0.5 0.5 1.5 2.7 7.6 19.2 50.5 101.9 160.1 259.7 414.5 514.1 547.4 441.4 71 
Colon / Rectum 
-- -- 0.1 0.5 0.8 2.4 5.6 9.5 21.1 33.7 67.1 66.5 85.4 123.5 176.1 217.8 261.6 331.8 67 
Esophagus -- -- -- -- 0.1 0.2 0.3 0.8 1.9 6.1 9.5 19.6 30.7 36.8 54.7 51.8 58.7 51.1 67 
Hodgkin Lymphoma -- 0.5 1.1 2.7 5.4 5.6 4.9 2.9 3.6 3.4 2.7 3.1 4.3 4.2 5.2 5.9 3.8 3.6 42 
Kidney & Renal Pelvis 2.8 0.6 0.1 0.3 0.5 1.5 3.5 8.2 14.8 22.3 35.4 46.8 63.4 80.9 98.8 102.0 90.9 66.9 63 
Larynx -- -- 0.1 -- -- 0.2 0.3 0.5 0.8 2.8 6.5 14.1 16.8 23.1 29.6 29.5 34.8 18.9 66 
Leukemia 8.5 3.8 2.5 3.8 3.0 3.1 3.9 3.5 7.3 9.9 12.0 20.6 33.1 47.7 67.8 91.5 101.5 114.8 67 
Liver & Intrahepatic Bile 
Ducts 1.3 -- 0.3 0.3 0.4 0.2 0.4 1.3 2.1 6.1 18.1 39.2 52.0 49.9 51.1 63.5 65.1 47.5 64 
Melanoma of Skin  0.1  0.4 1.6 3.7 6.5 7.5 12.2 18.5 26.2 42.4 54.5 76.8 109.1 142.5 160.9 153.8 67 
Multiple Myeloma -- -- -- -- -- 0.3 0.2 1.2 2.6 6.2 8.2 14.0 21.3 27.5 43.1 44.2 60.2 46.7 67 
Non-Hodgkin Lymphoma 1.4 1.4 1.3 2.5 4.0 2.9 5.7 9.0 12.2 16.4 24.8 36.4 50.7 73.2 96.0 118.7 157.1 146.6 66 
Oral Cavity & Pharynx -- 0.2 0.1 0.4 0.6 1.4 2.1 3.5 8.6 20.6 33.9 48.0 61.6 65.1 68.2 74.2 56.4 49.1 62 
Pancreas -- -- 0.1 -- 0.1 0.2 0.6 1.4 3.3 8.0 13.6 25.4 35.3 54.2 71.4 87.5 104.1 108.7 69 
Prostate 0.1 -- -- -- -- -- 0.1 0.3 8.1 34.7 142.4 272.9 447.9 589.9 621.9 479.9 316.1 324.2 65 
Stomach -- -- -- 0.1 -- 0.4 1.0 1.9 2.8 5.1 9.7 14.7 20.9 31.3 47.1 55.8 66.2 70.9 69 
Testis 0.3 0.1 0.1 2.9 11.0 16.2 14.9 14.0 10.7 8.3 6.7 3.5 2.2 1.5 1.6 0.6 1.5 1.2 35 
Thyroid 0.2 -- 0.4 1.1 3.4 6.0 9.9 13.6 15.3 16.4 17.1 22.2 22.1 23.1 24.5 23.2 19.3 8.1 54 
Urinary Bladder -- -- -- 0.3 0.6 0.7 1.3 2.4 5.8 12.2 26.4 43.3 82.0 135.9 221.5 281.3 344.5 405.1 72 
Other Sites 8.4 3.1 3.0 5.5 4.1 4.8 7.2 10.4 15.1 23.7 31.2 51.5 78.3 109.8 168.6 246.4 329.0 387.4 70 
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Table 2.  
AGE-SPECIFIC INCIDENCE RATES
1
 AND MEDIAN AGE AT DIAGNOSIS FOR SELECTED CANCER SITES 
Massachusetts, 2011-2015 
FEMALES 
 
 
1
 per 100,000    
2
 Breast in situ is excluded from ‘All Sites’.  3 Dashes indicate age groups with no incident cases. Source: Massachusetts Cancer Registry
Cancer Site / Type 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ 
Median 
Age 
All Sites 23.6 12.4 15.8 21.4 44.5 75.4 129.4 201.2 330.7 473.7 659.0 812.1 1090.2 1462.4 1827.6 2038.6 2079.2 1799.4 66 
Brain & Other Nervous System 3.6 3.7 3.6 2.8 2.4 2.7 3.2 3.8 4.7 4.2 5.7 8.7 11.4 14.7 17.5 19.3 21.9 17.1 61 
Breast -- -- 0.1 0.1 1.8 10.7 30.4 70.6 141.2 216.0 254.4 274.1 365.8 465.7 508.3 490.2 451.2 322.1 62 
Breast in situ2 -- -- -- 0.2 0.2 1.1 4.9 14.0 65.1 101.8 101.3 93.3 101.9 124.3 115.1 104.5 64.6 25.8 57 
Bronchus & Lung 0.1 -- 0.1 0.4 0.5 0.4 0.8 2.9 10.3 23.9 57.7 95.5 145.1 238.7 383.1 435.7 396.5 267.0 71 
Cervix Uteri -- -- -- 0.1 0.4 2.6 6.7 8.9 10.4 8.9 8.4 6.7 9.0 9.6 7.5 7.3 8.7 7.4 51 
Colon / Rectum  0.1 0.3 0.7 1.2 2.5 5.0 11.3 20.7 28.6 52.1 46.4 60.5 86.3 129.9 181.7 222.7 254.7 71 
Corpus Uteri & Uterus, NOS -- -- 0.1 -- 0.2 1.9 2.7 9.7 14.8 26.8 52.9 81.6 112.6 135.1 124.4 96.5 84.3 52.8 63 
Esophagus -- -- -- -- -- -- 0.3 -- 0.8 1.2 1.2 3.5 6.3 9.4 13.0 11.8 13.9 14.2 71 
Hodgkin Lymphoma -- -- 0.9 3.4 6.0 4.3 3.9 2.9 3.0 1.4 2.4 2.8 2.9 2.5 2.8 3.4 4.5 1.7 38 
Kidney & Renal Pelvis 1.9 0.8 0.3 0.3 0.3 1.3 2.6 4.2 7.1 10.0 16.3 20.8 27.2 35.7 46.4 54.1 47.2 35.1 66 
Larynx -- -- -- -- -- -- -- 0.1 0.2 1.0 2.9 4.5 2.9 6.7 8.3 5.6 4.5 5.5 67 
Leukemia 7.6 4.1 1.9 1.2 2.8 3.2 2.4 3.5 5.0 5.3 9.1 13.7 18.4 24.6 34.1 50.4 54.4 61.5 68 
Liver & Intrahepatic Bile Ducts 0.3 -- 0.2 0.3 0.3 0.1 0.5 0.5 1.1 1.7 4.1 8.6 12.9 12.4 15.1 22.5 23.1 19.9 68 
Melanoma of Skin 0.2 0.2 0.5 0.7 4.1 9.8 12.7 11.1 16.7 19.9 25.8 29.6 37.1 42.1 50.5 56.4 65.9 58.7 61 
Multiple Myeloma -- -- -- -- -- 0.3 0.2 1.0 1.2 3.2 6.1 9.9 13.4 20.9 23.3 31.3 35.8 31.5 70 
Non-Hodgkin Lymphoma 0.1 0.6 0.9 1.2 1.8 2.5 3.7 5.9 8.9 12.7 19.7 26.6 40.7 53.9 66.8 82.4 105.2 80.9 68 
Oral Cavity & Pharynx -- -- 0.3 0.5 0.6 0.8 1.8 2.6 4.1 6.2 10.6 15.3 18.9 25.8 29.3 31.3 31.1 32.5 66 
Ovary 0.2 0.1 0.5 1.1 1.5 2.4 3.7 4.5 6.2 13.8 22.3 25.4 30.5 35.4 42.4 48.3 44.7 38.9 63 
Pancreas -- -- -- 0.1 0.1 -- 0.5 1.4 2.3 4.2 9.4 15.2 24.7 42.7 61.4 75.3 89.5 101.4 74 
Stomach -- -- -- 0.2 0.4 0.4 0.5 1.5 3.4 4.2 4.7 7.6 9.0 12.9 19.3 24.2 33.1 35.3 71 
Thyroid 0.2 0.1 1.9 4.5 17.0 24.4 40.1 43.8 49.8 54.5 52.1 48.5 46.1 47.8 41.1 36.5 24.4 12.7 50 
Urinary Bladder -- -- 0.3 0.3 0.2 0.1 0.5 1.1 2.4 3.2 9.0 16.2 26.0 38.1 62.4 79.2 88.7 81.1 73 
Other Sites 9.3 2.7 3.7 3.5 2.9 4.9 7.2 10 16.4 23.0 31.8 51.0 68.9 101.1 140.8 195.2 228.0 267.0 71 
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Table 3.  
AGE-SPECIFIC INCIDENCE RATES
1
 AND MEDIAN AGE AT DIAGNOSIS FOR SELECTED CANCER SITES 
Massachusetts, 2011-2015 
TOTAL   
 
 
1
 per 100,000    
2
 Breast in situ is excluded from ‘All Sites’.  3 Dashes indicate age groups with no incident cases or cancers found in only one sex. Source: Massachusetts 
Cancer Registry
Cancer Site / Type 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ 
Median 
Age 
All Sites 26.1 13.1 13.8 22.5 41.5 65.3 102.2 150.9 248.2 379.6 606.9 854.4 1210.5 1639.0 2089.5 2308.9 2373.4 2122.7 66 
Brain & Other Nervous System 4.4 3.7 3.1 2.8 2.4 3.8 3.6 3.7 4.6 5.1 7.1 10.0 13.8 17.4 21.9 23.7 25.5 18.5 60 
Breast -- 0.1 0.1 0.0 0.9 5.4 15.5 36.1 72.7 111.1 131.2 142.9 193.2 250.1 281.9 281.5 276.7 221.6 62 
Breast in situ2 -- -- -- 0.1 0.1 0.6 2.5 7.2 33.5 52.2 52.0 48.4 53.5 66.3 63.5 60.1 39.2 17.8 57 
Bronchus & Lung 0.1 -- 0.1 0.3 0.5 0.5 1.1 2.8 9.0 21.6 54.2 98.7 152.3 248.5 397.4 469.5 456.3 322.9 71 
Cervix Uteri -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 
Colon / Rectum -- 0.1 0.2 0.6 1.0 2.5 5.3 10.4 21.0 31.1 59.4 56.1 72.3 103.7 150.8 197.3 238.1 279.4 69 
Corpus Uteri & Uterus, NOS -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 
Esophagus -- -- -- -- 0.0 0.1 0.3 0.4 1.3 3.6 5.2 11.2 17.9 22.3 31.9 29.1 31.7 26.1 68 
Hodgkin Lymphoma -- 0.3 1.0 3.1 5.7 5.0 4.4 2.9 3.3 2.4 2.6 2.9 3.5 3.4 3.9 4.5 4.2 2.3 40 
Kidney & Renal Pelvis 2.4 0.7 0.2 0.3 0.4 1.4 3.1 6.2 10.9 16.0 25.6 33.3 44.5 56.9 70.1 74.7 64.5 45.3 64 
Larynx -- -- 0.1 -- -- 0.1 0.1 0.3 0.5 1.8 4.7 9.1 9.5 14.4 17.9 15.9 16.5 9.8 66 
Leukemia 8.1 4.0 2.2 2.5 2.9 3.1 3.2 3.5 6.1 7.5 10.5 17.0 25.4 35.4 49.3 68.1 73.1 78.6 67 
Liver & Intrahepatic Bile Ducts 0.8 -- 0.3 0.3 0.4 0.1 0.4 0.9 1.6 3.9 10.9 23.4 31.6 30.0 31.4 40.2 39.8 28.8 64 
Melanoma of Skin 0.1 0.2 0.3 0.6 2.8 6.8 9.6 9.3 14.5 19.2 26.0 35.8 45.4 58.3 77.0 93.5 103.7 89.2 65 
Multiple Myeloma -- -- -- -- -- 0.3 0.2 1.1 1.9 4.7 7.2 11.9 17.2 24.0 32.2 36.9 45.5 36.4 69 
Non-Hodgkin Lymphoma 0.8 1.1 1.1 1.9 2.9 2.7 4.7 7.5 10.5 14.5 22.2 31.3 45.4 63.0 80.1 98.0 125.7 102.0 67 
Oral Cavity & Pharynx -- 0.1 0.2 0.5 0.6 1.1 2.0 3.1 6.3 13.2 21.9 31.0 39.2 44.2 46.9 49.8 41.1 37.8 63 
Ovary -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 
Pancreas -- -- 0.1 0.0 0.1 0.1 0.5 1.4 2.8 6.0 11.4 20.1 29.8 48.1 65.9 80.6 95.3 103.8 71 
Prostate -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 
Stomach -- -- 0.1 0.1 0.2 0.4 0.8 1.7 3.1 4.6 7.1 11.0 14.6 21.5 31.9 37.8 46.2 46.7 70 
Testis -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 
Thyroid 0.2 0.1 1.2 2.8 10.2 15.2 25.2 29.0 33.0 35.9 35.1 35.8 34.7 36.3 33.6 30.8 22.4 11.2 51 
Urinary Bladder -- -- 0.2 0.3 0.4 0.4 0.9 1.7 4.1 7.6 17.5 29.2 52.7 83.9 134.4 166.3 190.1 184.9 72 
Other Sites 8.9 2.9 3.4 4.5 3.5 4.8 7.2 10.2 15.7 23.4 31.5 51.3 73.4 105.2 153.5 217.3 268.0 305.7 70 
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Figure 5. 
ANNUAL PERCENT CHANGE (APC) IN AGE-ADJUSTED CANCER RATES AMONG MALES 
Massachusetts, 2011-2015  
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 *APC is statistically significant (p < 0.05).  Values appearing directly on a bar have been bolded for ease of reading only. ^ indicates a medium reliability trend (CV between 15 
and 30). NA indicates an unreliable trend (CVgreater than 30) therefore the APC is not presented. Source: Massachusetts Cancer Registry 
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Figure 6. 
ANNUAL PERCENT CHANGE (APC) IN AGE-ADJUSTED CANCER RATES AMONG FEMALES 
Massachusetts, 2011-2015 
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*APC is statistically significant (p < 0.05).  Values appearing directly on a bar have been bolded for ease of reading only. ^ indicates a medium reliability trend (CV between 15 
and 30). NA indicates an unreliable trend (CVgreater than 30) therefore the APC is not presented Source: Massachusetts Cancer Registry.                                         
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Table 4. 
ANNUAL AGE-ADJUSTED
1
 INCIDENCE RATES
2
 FOR SELECTED CANCER SITES 
Massachusetts, 2011-2015 
MALES 
Cancer Site / Type 2011 2012 2013 2014 2015 
All Sites 538.9 500.6 483.5 480.9 470.4 
Brain & Other Nervous System 7.9 7.4 9.1 7.6 7.2 
Breast 1.5 1.2 1.5 1.4 1.3 
Breast in situ
3 
 0.2 0.2 0.1 0.1 0.3 
Bronchus & Lung 74.5 71.2 67.1 68.6 65.5 
Colon / Rectum 43.5 42.2 40.7 44.2 39.0 
Esophagus 11.0 9.8 9.8 9.2 8.7 
Hodgkin Lymphoma 3.6 3.6 3.1 3.1 2.8 
Kidney & Renal Pelvis 20.6 20.9 23.2 23.3 23.8 
Larynx 5.3 5.2 6.3 5.7 5.2 
Leukemia 17.3 17.6 16.0 16.4 15.2 
Liver & Intrahepatic Bile Ducts 12.4 14.2 12.5 12.5 12.8 
Melanoma of Skin 29.2 25.8 25.0 22.8 21.5 
Multiple Myeloma 8.0 8.2 8.9 7.5 8.0 
Non-Hodgkin Lymphoma 22.6 22.9 23.6 24.0 23.8 
Oral Cavity & Pharynx 18.0 18.7 16.7 18.0 17.7 
Pancreas 14.3 14.3 14.8 13.9 15.3 
Prostate 138.2 107.0 97.7 93.3 98.4 
Stomach 9.0 8.9 10.3 10.0 8.5 
Testis 6.7 6.7 6.6 6.5 6.1 
Thyroid 10.8 10.4 9.3 11.4 11.4 
Urinary Bladder 41.6 42.4 39.7 39.1 39.6 
 
 
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
per 100,000 males 
3
Breast in situ is excluded from “All Sites” 
 
Source: Massachusetts Cancer Registry 
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Table 5. 
ANNUAL AGE-ADJUSTED
1
 INCIDENCE RATES
2
 FOR SELECTED CANCER SITES 
Massachusetts, 2011-2015 
FEMALES 
Cancer Site / Type 2011 2012 2013 2014 2015 
All Sites 457.4 457.0 447.3 447.3 446.0 
Brain & Other Nervous System 6.3 5.6 6.1 5.6 6.4 
Breast 137.3 137.1 137.4 138.7 137.6 
Breast in situ
3 
 41.6 42.6 42.6 40.9 39.0 
Bronchus & Lung 60.8 61.1 60.8 58.7 59.6 
Cervix Uteri 5.1 5.0 4.9 5.5 5.1 
Colon / Rectum  34.3 33.2 33.2 32.3 32.8 
Corpus Uteri & Uterus, NOS 31.2 28.3 29.8 27.6 30.0 
Esophagus 2.0 1.7 2.4 2.6 2.3 
Hodgkin Lymphoma 2.7 2.6 2.4 2.8 2.7 
Kidney & Renal Pelvis 10.6 10.9 10.7 10.8 10.9 
Larynx 1.4 1.8 1.2 1.2 1.4 
Leukemia 10.2 9.9 10.2 9.0 10.1 
Liver & Intrahepatic Bile Ducts 3.3 3.8 4.1 4.1 3.6 
Melanoma of Skin 18.6 17.8 16.2 15.7 15.7 
Multiple Myeloma 6.0 5.2 5.3 5.0 4.8 
Non-Hodgkin Lymphoma 15.8 17.9 16.9 15.9 15.1 
Oral Cavity & Pharynx 6.2 7.9 7.3 6.7 7.5 
Ovary 12.1 12.9 10.5 11.3 11.2 
Pancreas 10.9 11.0 11.6 12.2 12.0 
Stomach 4.5 4.3 4.3 5.0 5.1 
Thyroid 30.7 29.7 27.0 31.4 29.0 
Urinary Bladder 12.1 11.7 10.8 10.9 10.7 
 
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
per 100,000 males 
3
Breast in situ is excluded from “All Sites” 
 
Source: Massachusetts Cancer Registry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
 
 
Table 6. 
ANNUAL AGE-ADJUSTED
1
 INCIDENCE RATES
2
 FOR SELECTED CANCER SITES 
Massachusetts, 2011-2015 
TOTAL 
Cancer Site / Type 2011 2012 2013 2014 2015 
All Sites 489.8 472.6 459.8 457.9 452.5 
Brain & Other Nervous System 7.0 6.4 7.5 6.5 6.8 
Breast -- -- -- -- -- 
Breast in situ
3 
 -- -- -- -- -- 
Bronchus & Lung 66.4 65.0 63.2 62.6 61.8 
Cervix Uteri -- -- -- -- -- 
Colon / Rectum 38.3 37.2 36.5 37.6 35.5 
Corpus Uteri & Uterus, NOS -- -- -- -- -- 
Esophagus 5.9 5.3 5.7 5.5 5.2 
Hodgkin Lymphoma 3.1 3.1 2.7 3.0 2.8 
Kidney & Renal Pelvis 15.3 15.5 16.4 16.5 16.8 
Larynx 3.2 3.3 3.5 3.2 3.1 
Leukemia 13.3 13.3 12.7 12.2 12.3 
Liver & Intrahepatic Bile Ducts 7.5 8.5 8.0 7.9 7.7 
Melanoma of Skin 23.0 21.0 19.8 18.7 18.0 
Multiple Myeloma 6.9 6.5 6.9 6.1 6.2 
Non-Hodgkin Lymphoma 18.7 20.0 19.9 19.5 18.9 
Oral Cavity & Pharynx 11.6 12.9 11.7 11.9 12.3 
Ovary -- -- -- -- -- 
Pancreas 12.5 12.6 13.0 13.0 13.5 
Prostate -- -- -- -- -- 
Stomach 6.5 6.4 6.9 7.2 6.5 
Testis 3.3 3.3 3.3 3.2 3.0 
Thyroid 21.0 20.3 18.5 21.7 20.4 
Urinary Bladder 24.6 24.8 23.1 22.8 23.0 
 
 
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
per 100,000 total population 
3
Breast in situ is excluded from “All Sites” 
4
Dashes indicate cancers found in only one sex or predominantly in one sex (breast cancer). 
 
Source: Massachusetts Cancer Registry
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Table 7. 
ANNUAL AGE-ADJUSTED
1
 MORTALITY RATES
2
 FOR SELECTED CANCER SITES 
Massachusetts, 2011-2015 
MALES 
 
 
 
Cancer Site / Type 2011 2012 2013 2014 2015 
All Sites 197.5 190.1 185.9 184.6 177.1 
Brain & Other Nervous System 5.0 5.0 5.2 5.2 5.8 
Breast 0.2 0.4 0.4 0.4 0.1 
Bronchus & Lung 47.6 48.3 46.2 45.7 43.7 
Colon / Rectum 14.7 14.6 13.8 14.7 13.0 
Esophagus 8.3 8.4 7.5 8.1 8.6 
Hodgkin Lymphoma 0.2 0.3 0.3 0.3 0.3 
Kidney & Renal Pelvis 4.0 4.5 4.7 5.3 5.1 
Larynx 1.7 1.2 1.4 1.5 1.2 
Leukemia 8.4 8.1 9.0 7.9 7.3 
Liver & Intrahepatic Bile Ducts 9.0 8.8 10.2 9.5 9.1 
Melanoma of Skin 3.7 3.7 4.0 3.8 3.2 
Multiple Myeloma 3.8 3.7 3.3 4.1 3.8 
Non-Hodgkin Lymphoma 7.2 5.9 6.2 6.4 6.5 
Oral Cavity & Pharynx 3.5 3.6 3.5 3.2 3.5 
Pancreas 11.8 11.2 12.4 11.7 12.1 
Prostate 17.4 17.4 17.5 17.9 17.5 
Stomach 3.7 3.9 3.4 4.1 4.5 
Testis 0.1 0.2 0.2 0.03 0.1 
Thyroid 0.7 0.6 0.7 0.5 0.7 
Urinary Bladder 7.5 7.1 7.7 7.6 7.9 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
 per 100,000 males 
 
Source: Massachusetts Vital Statistics 
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Table 8 
ANNUAL AGE-ADJUSTED
1
 MORTALITY RATES
2
 FOR SELECTED CANCER SITES 
Massachusetts, 2011-2015 
FEMALES 
 
 
 
Cancer Site / Type 2011 2012 2013 2014 2015 
All Sites 139.4 138.6 136.2 130.1 131.8 
Brain & Other Nervous System 3.6 3.4 3.4 3.4 3.7 
Breast 18.1 18.2 17.6 17.3 17.2 
Bronchus & Lung 35.7 35.9 34.5 34.5 34.6 
Cervix Uteri 1.4 1.2 0.9 1.2 1.0 
Colon / Rectum 9.9 10.6 11.0 10.1 10.4 
Corpus Uteri & Uterus, NOS 4.3 3.9 4.8 4.3 4.7 
Esophagus 1.4 1.4 1.2 1.9 1.8 
Hodgkin Lymphoma 0.2 0.2 0.2 0.1 0.2 
Kidney & Renal Pelvis 2.2 2.0 2.0 1.8 2.2 
Larynx 0.5 0.3 0.4 0.3 0.4 
Leukemia 4.7 4.9 5.0 4.2 4.4 
Liver & Intrahepatic Bile Ducts 3.0 3.2 3.7 3.6 3.3 
Melanoma of Skin 1.8 1.8 2.1 1.7 1.6 
Multiple Myeloma 2.5 2.7 2.6 2.6 2.2 
Non-Hodgkin Lymphoma 4.1 4.0 4.3 4.1 4.0 
Oral Cavity & Pharynx 1.1 1.0 1.2 1.3 1.3 
Ovary 7.8 6.7 7.6 6.5 6.8 
Pancreas 9.4 9.3 8.9 9.5 10.2 
Stomach 2.1 2.3 2.4 2.2 2.1 
Thyroid 0.5 0.3 0.5 0.4 0.4 
Urinary Bladder 2.3 2.5 2.6 2.1 2.3 
 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
 per 100,000 females 
 
Source: Massachusetts Vital Statistics 
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Table 9. 
ANNUAL AGE-ADJUSTED
1
 MORTALITY RATES
2
 FOR SELECTED CANCER SITES 
Massachusetts, 2011-2015 
TOTAL
3
 
 
 
 
Cancer Site / Type 2011 2012 2013 2014 2015 
All Sites 162.7 159.6 156.4 152.4 150.0 
Brain & Other Nervous System 4.3 4.1 4.2 4.2 4.7 
Breast - - - - - 
Bronchus & Lung 40.7 41.1 39.3 39.2 38.3 
Cervix Uteri - - - - - 
Colon / Rectum 12.0 12.3 12.2 12.1 11.6 
Corpus Uteri & Uterus, NOS - - - - - 
Esophagus 4.4 4.5 4.0 4.6 4.8 
Hodgkin Lymphoma 0.2 0.2 0.2 0.2 0.2 
Kidney & Renal Pelvis 3.0 3.1 3.2 3.4 3.5 
Larynx 1.0 0.7 0.8 0.8 0.8 
Leukemia 6.2 6.2 6.7 5.7 5.7 
Liver & Intrahepatic Bile Ducts 5.7 5.7 6.7 6.2 5.8 
Melanoma of Skin 2.6 2.6 2.9 2.6 2.3 
Multiple Myeloma 3.1 3.2 2.9 3.2 2.9 
Non-Hodgkin Lymphoma 5.4 4.8 5.1 5.1 5.1 
Oral Cavity & Pharynx 2.2 2.2 2.3 2.2 2.3 
Ovary - - - - - 
Pancreas 10.5 10.2 10.5 10.5 11.1 
Prostate - - - - - 
Stomach 2.8 3.0 2.8 3.0 3.1 
Testis - - - - - 
Thyroid 0.6 0.4 0.6 0.4 0.5 
Urinary Bladder 4.4 4.3 4.7 4.3 4.5 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
 per 100,000 total population 
3
Dashes indicate cancers found in only one sex or predominantly in one sex (breast cancer). 
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Table 10. 
FIVE LEADING CANCER INCIDENCE RATES BY RACE/ETHNICITY AND SEX 
 Massachusetts, 2011-2015   
   
MALES 
 
AGE-ADJUSTED
1
 INCIDENCE RATE
2
 
RANK White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
1 
Prostate 
100.2 
Prostate 
182.5 
Bronchus & Lung 
57.7 
Prostate 
107.5 
 
2 
Bronchus & Lung 
71.2 
Bronchus & Lung 
64.8 
Prostate 
56.5 
Bronchus & Lung 
38.9 
3 
Urinary Bladder 
42.9 
Colon / Rectum 
46.9 
Colon / Rectum 
32.4 
Colon / Rectum 
35.3 
 
4 
Colon / Rectum 
41.9 
Kidney and Renal 
Pelvis 
21.8 
Liver and Intrahepatic 
Bile Ducts 
25.9 
Liver and 
Intrahepatic Bile 
Ducts 
21.8 
5 
Melanoma of Skin 
27.3 
Liver and Intrahepatic 
Bile Ducts 
19.4 
Urinary Bladder 
14.6 
Non-Hodgkin 
Lymphoma 
20.1 
 
FEMALES 
 
AGE-ADJUSTED
1
 INCIDENCE RATE
2
 
RANK White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
1 
Breast 
143.7 
Breast 
121.5 
Breast 
90.8 
Breast 
90.0  
   
2 
Bronchus & Lung 
63.8 
Bronchus & Lung 
43.3 
Bronchus & Lung 
33.1 
Thyroid 
28.5 
 
3 
Colon / Rectum 
33.3 
Colon / Rectum 
35.4 
Thyroid 
29.6 
Bronchus & Lung 
27.8 
 
4 
Corpus Uteri & 
Uterus, NOS 
30.4 
Corpus Uteri & 
Uterus, NOS 
26.7 
Colon / Rectum 
28.4 
Colon / Rectum 
25.3 
5 
Thyroid 
29.7 
Thyroid 
22.8 
Corpus Uteri & 
Uterus, NOS 
15.4 
Corpus Uteri & 
Uterus, NOS 
21.2 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
 per 100,000 
3
Breast cancer rates do not include in situ cases.  
 
Source:  Massachusetts Cancer Registry 
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Table 11.  
NUMBER AND PERCENTAGE OF INCIDENT CASES FOR SELECTED CANCER SITES BY RACE/ETHNICITY
1
 
Massachusetts, 2011-2015 
MALES 
 
  All Races
2
 White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
Cancer Site / Type Cases % of Cases Cases % of Cases Cases % of Cases Cases % of Cases Cases % of Cases 
All Sites 87884 100.0 76121 100.0 4535 100.0 2216 100.0 3344 100.0 
Brain & Other Nervous System 1347 1.5 1193 1.6 46 1.0 32 1.4 65 1.9 
Breast
3
 242 0.3 210 0.3 12 0.3 11 0.5 9 0.3 
Bronchus & Lung 11999 13.7 10799 14.2 503 11.1 364 16.4 281 8.4 
Colon / Rectum 7291 8.3 6282 8.3 404 8.9 233 10.5 292 8.7 
Esophagus 1747 2.0 1618 2.1 58 1.3 35 1.6 26 0.8 
Hodgkin Lymphoma 547 0.6 445 0.6 32 0.7 17 0.8 48 1.4 
Kidney & Renal Pelvis 4028 4.6 3506 4.6 198 4.4 80 3.6 189 5.7 
Larynx 1013 1.2 896 1.2 41 0.9 6 0.3 56 1.7 
Leukemia 2793 3.2 2441 3.2 111 2.4 72 3.2 104 3.1 
Liver & Intrahepatic Bile Ducts 2436 2.8 1823 2.4 196 4.3 190 8.6 199 6.0 
Melanoma of Skin 4305 4.9 4047 5.3 8 0.2 10 0.5 16 0.5 
Multiple Myeloma 1429 1.6 1188 1.6 120 2.6 33 1.5 70 2.1 
Non-Hodgkin Lymphoma 4045 4.6 3543 4.7 167 3.7 95 4.3 193 5.8 
Oral Cavity & Pharynx 3327 3.8 2931 3.9 129 2.8 111 5.0 128 3.8 
Pancreas 2556 2.9 2277 3.0 131 2.9 54 2.4 76 2.3 
Prostate 20389 23.2 16641 21.9 1694 37.4 385 17.4 923 27.6 
Stomach 1624 1.8 1266 1.7 138 3.0 83 3.7 111 3.3 
Testis 1045 1.2 931 1.2 17 0.4 19 0.9 60 1.8 
Thyroid 1851 2.1 1564 2.1 60 1.3 104 4.7 80 2.4 
Urinary Bladder 6872 7.8 6422 8.4 136 3.0 89 4.0 141 4.2 
Other Sites 6998 8.0 6098 8.0 334 7.4 193 8.7 277 8.3 
 
                                                 
1
 Race/ethnicity categories are mutually exclusive.  Cases are only included in one race/ethnicity category. 
2
 The number of cases for all races is not the sum of cases by race/ethnicity.  
3
Breast in situ cases are excluded from ‘All Sites’ and breast cancer counts. 
 
Source:  Massachusetts Cancer Registry 
 31 
 
Table 12. 
NUMBER AND PERCENTAGE OF INCIDENT CASES FOR SELECTED CANCER SITES BY RACE/ETHNICITY
1
 
Massachusetts, 2011-2015 
FEMALES 
 
  All Races
2
 White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
Cancer Site / Type Cases % of Cases Cases % of Cases Cases % of Cases Cases % of Cases Cases % of Cases 
All Sites 95757 100.0 83467 100.0 4522 100.0 2760 100.0 3904 100.0 
Brain & Other Nervous System 1169 1.2 1004 1.2 49 1.1 43 1.6 64 1.6 
Breast
3
 28737 30.0 25182 30.2 1391 30.8 871 31.6 1117 28.6 
Bronchus & Lung 13239 13.8 12182 14.6 475 10.5 257 9.3 268 6.9 
Cervix Uteri 949 1.0 658 0.8 93 2.1 72 2.6 119 3.0 
Colon / Rectum 7284 7.6 6313 7.6 399 8.8 235 8.5 273 7.0 
Corpus Uteri & Uterus, NOS 6463 6.7 5673 6.8 309 6.8 144 5.2 261 6.7 
Esophagus 493 0.5 445 0.5 22 0.5 9 0.3 14 0.4 
Hodgkin Lymphoma 472 0.5 385 0.5 22 0.5 12 0.4 51 1.3 
Kidney & Renal Pelvis 2281 2.4 1975 2.4 129 2.9 41 1.5 111 2.8 
Larynx 316 0.3 284 0.3 17 0.4 3 0.1 8 0.2 
Leukemia 2064 2.2 1763 2.1 81 1.8 65 2.4 106 2.7 
Liver & Intrahepatic Bile Ducts 847 0.9 646 0.8 59 1.3 70 2.5 61 1.6 
Melanoma of Skin 3452 3.6 3197 3.8 12 0.3 6 0.2 38 1.0 
Multiple Myeloma 1182 1.2 914 1.1 150 3.3 19 0.7 86 2.2 
Non-Hodgkin Lymphoma 3536 3.7 3046 3.6 153 3.4 88 3.2 193 4.9 
Oral Cavity & Pharynx 1552 1.6 1350 1.6 59 1.3 59 2.1 65 1.7 
Ovary 2477 2.6 2159 2.6 107 2.4 88 3.2 91 2.3 
Pancreas 2636 2.8 2323 2.8 140 3.1 67 2.4 83 2.1 
Stomach 1027 1.1 766 0.9 94 2.1 74 2.7 83 2.1 
Thyroid 5440 5.7 4266 5.1 274 6.1 315 11.4 432 11.1 
Urinary Bladder 2526 2.6 2340 2.8 76 1.7 18 0.7 54 1.4 
Other Sites 7615 8.0 6596 7.9 411 9.1 204 7.4 326 8.4 
 
                                                 
1
 Race/ethnicity categories are mutually exclusive.  Cases are only included in one race/ethnicity category. 
2
 The number of cases for all races is not the sum of cases by race/ethnicity.  
3
Breast in situ cases are excluded from ‘All Sites’ and from breast cancer counts. 
 
 Source: Massachusetts Cancer Registry 
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Table 13. 
NUMBER AND PERCENTAGE OF INCIDENT CASES FOR SELECTED CANCER SITES BY RACE/ETHNICITY
1
 
Massachusetts, 2011-2015 
TOTAL
2
 
 
  All Races3 White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
Cancer Site / Type Cases % of Cases Cases % of Cases Cases % of Cases Cases % of Cases Cases % of Cases 
All Sites 183661 100.0 159603 100.0 9059 100.0 4977 100.0 7248 100.0 
Brain & Other Nervous System 2517 1.4 2198 1.4 95 1.0 75 1.5 129 1.8 
Breast
4 28980 15.8 25393 15.9 1403 15.5 882 17.7 1126 15.5 
Bronchus & Lung 25241 13.7 22983 14.4 978 10.8 621 12.5 549 7.6 
Cervix Uteri 949 0.5 658 0.4 93 1.0 72 1.4 119 1.6 
Colon / Rectum 14576 7.9 12596 7.9 803 8.9 468 9.4 565 7.8 
Corpus Uteri & Uterus, NOS 6464 3.5 5674 3.6 309 3.4 144 2.9 261 3.6 
Esophagus 2240 1.2 2063 1.3 80 0.9 44 0.9 40 0.6 
Hodgkin Lymphoma 1020 0.6 831 0.5 54 0.6 29 0.6 99 1.4 
Kidney & Renal Pelvis 6310 3.4 5482 3.4 327 3.6 121 2.4 300 4.1 
Larynx 1329 0.7 1180 0.7 58 0.6 9 0.2 64 0.9 
Leukemia 4857 2.6 4204 2.6 192 2.1 137 2.8 210 2.9 
Liver & Intrahepatic Bile Ducts 3284 1.8 2469 1.5 255 2.8 261 5.2 260 3.6 
Melanoma of Skin 7758 4.2 7245 4.5 20 0.2 16 0.3 54 0.7 
Multiple Myeloma 2611 1.4 2102 1.3 270 3.0 52 1.0 156 2.2 
Non-Hodgkin Lymphoma 7583 4.1 6590 4.1 321 3.5 183 3.7 386 5.3 
Oral Cavity & Pharynx 4879 2.7 4281 2.7 188 2.1 170 3.4 193 2.7 
Ovary 2478 1.3 2160 1.4 107 1.2 88 1.8 91 1.3 
Pancreas 5192 2.8 4600 2.9 271 3.0 121 2.4 159 2.2 
Prostate 20389 11.1 16641 10.4 1694 18.7 385 7.7 923 12.7 
Stomach 2651 1.4 2032 1.3 232 2.6 157 3.2 194 2.7 
Testis 1045 0.6 931 0.6 17 0.2 19 0.4 60 0.8 
Thyroid 7292 4.0 5830 3.7 335 3.7 419 8.4 512 7.1 
Urinary Bladder 9399 5.1 8763 5.5 212 2.3 107 2.1 195 2.7 
Other Sites 14617 8.0 12697 8.0 745 8.2 397 8.0 603 8.3 
                                                 
1
 Race/ethnicity categories are mutually exclusive.  Cases are only included in one race/ethnicity category. 
2
Total includes persons classified as a transsexual and persons of unknown sex.  
3
The number of cases for all races is not the sum of cases by race/ethnicity.         
4 Breast in situ cases are excluded from ‘All Sites’ and from breast cancer counts.  Source: Massachusetts Cancer Registry 
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Table 14. 
AGE-ADJUSTED
1
 INCIDENCE RATES
2
 AND 95% CONFIDENCE LIMITS (95% CL)  
FOR SELECTED CANCER SITES BY RACE/ETHNICITY
3
 
Massachusetts, 2011-2015 
MALES 
 
  All Races White, non-Hispanics Black, non-Hispanics Asian, non-Hispanics Hispanics 
Cancer Site / Type Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL 
All Sites 493.9 490.6-497.3 498.2 494.5-501.8 514.6 498.4-530.7 312.4 298.6-326.2 376.6 362.0-391.1 
Brain & Other Nervous System 7.9 7.4-8.3 8.5 8.0-9.0 4.5 3.1-5.9 3.5 2.3-4.8 4.9 3.5-6.4 
Breast 1.4 1.2-1.6 1.4 1.2-1.6 * * * * * * 
Breast in situ
4
 0.2 0.1-0.2 0.2 0.1-0.2 * * * * * * 
Bronchus & Lung 69.3 68.0-70.6 71.2 69.8-72.5 64.8 58.7-70.9 57.7 51.5-64.0 38.9 33.9-44.0 
Colon / Rectum 41.8 40.9-42.8 41.9 40.9-43.0 46.9 41.9-51.8 32.4 28.0-36.8 35.3 30.6-40.1 
Esophagus 9.7 9.2-10.1 10.3 9.8-10.8 6.8 4.9-8.7 5.2 3.3-7.0 3.5 2.0-4.9 
Hodgkin Lymphoma 3.2 3.0-3.5 3.4 3.1-3.8 2.8 1.8-3.8 * * 3.5 2.2-4.8 
Kidney & Renal Pelvis 22.4 21.7-23.1 23.0 22.2-23.8 21.8 18.6-25.1 10.3 7.9-12.7 18.7 15.7-21.7 
Larynx 5.5 5.2-5.9 5.6 5.3-6.0 4.8 3.3-6.4 * * 6.3 4.5-8.2 
Leukemia 16.5 15.9-17.1 17.0 16.3-17.7 12.4 9.9-15.0 9.5 7.1-11.8 10.0 7.6-12.3 
Liver & Intrahepatic Bile Ducts 12.9 12.4-13.4 11.2 10.7-11.7 19.4 16.5-22.3 25.9 22.0-29.7 21.8 18.4-25.2 
Melanoma of Skin 24.8 24.0-25.6 27.3 26.4-28.1 * * * * * * 
Multiple Myeloma 8.1 7.7-8.5 7.8 7.3-8.2 14.5 11.7-17.3 4.4 2.8-5.9 7.4 5.5-9.3 
Non-Hodgkin Lymphoma 23.4 22.6-24.1 23.9 23.1-24.7 17.6 14.7-20.4 12.5 9.8-15.2 20.1 16.8-23.4 
Oral Cavity & Pharynx 17.8 17.2-18.4 18.3 17.6-19.0 14.2 11.6-16.8 13.9 11.2-16.6 14.3 11.5-17.1 
Pancreas 14.5 13.9-15.1 14.8 14.2-15.4 16.3 13.3-19.3 7.9 5.7-10.2 9.5 7.0-11.9 
Prostate 106.3 104.8-107.8 100.2 98.6-101.7 182.5 173.3-191.8 56.5 50.6-62.4 107.5 99.9-115.1 
Stomach 9.3 8.9-9.8 8.4 7.9-8.8 17.8 14.6-21.1 12.2 9.4-14.9 13.9 10.9-16.8 
Testis 6.5 6.1-6.9 8.0 7.4-8.5 * * * * 3.1 2.3-4.0 
Thyroid 10.6 10.2-11.1 11.2 10.6-11.8 6.1 4.5-7.7 10.7 8.6-12.9 6.5 4.9-8.1 
Urinary Bladder 40.4 39.4-41.4 42.9 41.8-43.9 18.1 14.8-21.3 14.6 11.3-17.8 19.2 15.6-22.7 
 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population.   
2
 per 100,000     
3
 Race/ethnicity categories are mutually exclusive. Cases are only included in one race/ethnicity category.  
4 
Breast in situ is excluded from ‘All Sites’. 
*An age-adjusted incidence rate was not calculated when there were fewer than 20 cases. 
 
Source: Massachusetts Cancer Registry 
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Table 15. 
AGE-ADJUSTED
1
 INCIDENCE RATES
2
 AND 95% CONFIDENCE LIMITS (95% CL) 
FOR SELECTED CANCER SITES BY RACE/ETHNICITY
3
 
Massachusetts, 2011-2015 
FEMALES 
 
  All Races White, non-Hispanics Black, non-Hispanics Asian, non-Hispanics Hispanics 
Cancer Site / Type Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL 
All Sites 450.9 448.0-453.8 464.5 461.2-467.8 399.1 387.3-410.9 307.2 295.3-319.1 327.0 315.9-338.0 
Brain & Other Nervous System 6.0 5.6-6.3 6.3 5.9-6.7 4.2 3.0-5.3 4.4 3.1-5.8 4.8 3.5-6.1 
Breast 137.6 136.0-139.3 143.7 141.9-145.6 121.5 115.0-128.0 90.8 84.6-97.0 90.0 84.4-95.6 
Breast in situ
4
 41.4 40.5-42.3 43.3 42.3-44.4 38.0 34.4-41.6 31.4 27.8-35.0 28.6 25.5-31.6 
Bronchus & Lung 60.2 59.1-61.2 63.8 62.6-64.9 43.3 39.3-47.3 33.1 28.9-37.3 27.8 24.3-31.3 
Cervix Uteri 5.1 4.8-5.5 4.6 4.2-4.9 8.2 6.5-9.8 7.1 5.4-8.8 9.5 7.6-11.3 
Colon / Rectum 33.1 32.3-33.9 33.3 32.5-34.2 35.4 31.9-39.0 28.4 24.6-32.1 25.3 22.1-28.5 
Corpus Uteri & Uterus, NOS 29.4 28.7-30.1 30.4 29.6-31.2 26.7 23.7-29.8 15.4 12.8-18.0 21.2 18.5-23.9 
Esophagus 2.2 2.0-2.4 2.2 2.0-2.5 1.9 1.1-2.7 * * * * 
Hodgkin Lymphoma 2.6 2.4-2.9 2.8 2.6-3.1 1.7 1.0-2.5 * * 3.3 2.3-4.3 
Kidney & Renal Pelvis 10.8 10.3-11.2 11.0 10.5-11.5 11.1 9.2-13.1 4.9 3.3-6.5 9.1 7.2-10.9 
Larynx 1.4 1.3-1.6 1.5 1.3-1.7 * * * * * * 
Leukemia 9.9 9.4-10.3 10.0 9.5-10.5 7.0 5.4-8.5 6.9 5.1-8.6 8.3 6.6-10.1 
Liver & Intrahepatic Bile Ducts 3.8 3.5-4.0 3.3 3.0-3.6 5.0 3.7-6.3 9.2 7.0-11.5 6.4 4.7-8.1 
Melanoma of Skin 16.8 16.2-17.3 19.0 18.3-19.7 * * * * 3.0 1.9-4.0 
Multiple Myeloma 5.3 5.0-5.6 4.6 4.3-5.0 13.7 11.5-16.0 2.4 1.3-3.5 8.1 6.3-10.0 
Non-Hodgkin Lymphoma 16.3 15.8-16.9 16.4 15.8-17.0 13.4 11.2-15.6 10.2 8.0-12.4 17.3 14.6-19.9 
Oral Cavity & Pharynx 7.1 6.8-7.5 7.2 6.8-7.6 4.9 3.6-6.2 6.9 5.1-8.7 5.8 4.3-7.3 
Ovary 11.6 11.1-12.1 12.0 11.5-12.5 9.1 7.3-10.8 9.4 7.4-11.5 7.0 5.5-8.5 
Pancreas 11.5 11.1-12.0 11.6 11.1-12.1 12.9 10.8-15.1 9.0 6.8-11.3 8.0 6.1-9.8 
Stomach 4.7 4.4-5.0 3.9 3.7-4.2 8.8 7.0-10.6 9.2 7.0-11.3 7.4 5.7-9.1 
Thyroid 29.6 28.7-30.4 29.7 28.8-30.7 22.8 20.0-25.5 29.6 26.3-33.0 28.5 25.7-31.4 
Urinary Bladder 11.2 10.8-11.7 12.0 11.5-12.5 7.3 5.6-8.9 * * 5.4 3.8-6.9 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
 per 100,000 
3
 Race/ethnicity categories are mutually exclusive. Cases are only included in one race/ethnicity category.  
4
 Breast in situ cases are excluded from ‘All Sites’. 
* An age-adjusted incidence rate was not calculated when there were fewer than 20 cases. 
 
Source: Massachusetts Cancer Registry 
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Table 16. 
AGE-ADJUSTED
1
 INCIDENCE RATES
2
 AND 95% CONFIDENCE LIMITS (95% CL)  
FOR SELECTED CANCER SITES BY RACE/ETHNICITY
3
 
Massachusetts, 2011-2015 
 TOTAL 
  All Races White, non-Hispanics Black, non-Hispanics Asian, non-Hispanics Hispanics 
Cancer Site / Type Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL 
All Sites 466.1 463.9-468.2 475.2 472.8-477.6 445.3 435.8-454.8 307.9 298.9-316.9 345.4 336.7-354.2 
Brain & Other Nervous System 6.8 6.6-7.1 7.3 7.0-7.6 4.3 3.4-5.2 4.0 3.1-5.0 4.9 3.9-5.9 
Breast --5 -- -- -- -- -- -- -- -- -- 
Breast in situ
4
 -- -- -- -- -- -- -- -- -- -- 
Bronchus & Lung 63.8 63.0-64.6 66.6 65.7-67.4 51.6 48.2-54.9 44.1 40.5-47.7 32.4 29.5-35.3 
Cervix Uteri -- -- -- -- -- -- -- -- -- -- 
Colon / Rectum 37.0 36.4-37.6 37.1 36.5-37.8 40.0 37.2-42.9 30.2 27.3-33.1 29.4 26.7-32.1 
Corpus Uteri & Uterus, NOS -- -- -- -- -- -- -- -- -- -- 
Esophagus 5.5 5.3-5.8 5.9 5.6-6.1 4.0 3.1-4.9 2.9 2.0-3.8 2.2 1.5-3.0 
Hodgkin Lymphoma 2.9 2.7-3.1 3.1 2.9-3.3 2.3 1.6-2.9 1.2 0.7-1.7 3.3 2.6-4.1 
Kidney & Renal Pelvis 16.1 15.7-16.5 16.5 16.1-17.0 15.7 13.9-17.5 7.4 6.0-8.8 13.3 11.6-14.9 
Larynx 3.3 3.1-3.4 3.3 3.2-3.5 2.9 2.1-3.7 * * 3.1 2.3-3.9 
Leukemia 12.8 12.4-13.1 13.1 12.6-13.5 9.1 7.8-10.5 8.0 6.6-9.4 9.0 7.6-10.4 
Liver & Intrahepatic Bile Ducts 7.9 7.7-8.2 6.9 6.6-7.2 11.5 10.0-12.9 17.0 14.8-19.1 13.2 11.4-14.9 
Melanoma of Skin 20.0 19.6-20.5 22.4 21.8-22.9 1.0 0.6-1.5 * * 2.4 1.7-3.1 
Multiple Myeloma 6.5 6.3-6.8 6.0 5.8-6.3 14.1 12.3-15.8 3.3 2.4-4.3 7.9 6.6-9.2 
Non-Hodgkin Lymphoma 19.4 19.0-19.9 19.7 19.2-20.2 15.3 13.6-17.1 11.3 9.5-13.0 18.5 16.5-20.6 
Oral Cavity & Pharynx 12.1 11.7-12.4 12.4 12.0-12.8 8.9 7.6-10.2 10.2 8.6-11.8 9.5 8.0-11.0 
Ovary -- -- -- -- -- -- -- -- -- -- 
Pancreas 12.9 12.5-13.3 13.1 12.7-13.5 14.6 12.8-16.4 8.5 6.9-10.1 8.6 7.1-10.0 
Prostate -- -- -- -- -- -- -- -- -- -- 
Stomach 6.7 6.4-7.0 5.9 5.6-6.1 12.4 10.8-14.1 10.6 8.8-12.3 10.1 8.5-11.7 
Testis -- -- -- -- -- -- -- -- -- -- 
Thyroid 20.4 19.9-20.9 20.7 20.1-21.2 15.0 13.4-16.7 20.7 18.6-22.7 18.2 16.5-19.8 
Urinary Bladder 23.6 23.1-24.1 25.2 24.6-25.7 11.6 10.0-13.2 7.8 6.2-9.3 11.1 9.4-12.8 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population.  
2
 per 100,000  
3
 Race/ethnicity categories are mutually exclusive.  Cases are only included in one race/ethnicity category.  
4
 Breast in situ cases are excluded from ‘All Sites’.     
5 
Dashes indicate cancers found in only one sex or predominantly in one sex (breast cancer).  * An age-adjusted incidence rate was not calculated when there 
were fewer than 20 cases.  Source: Massachusetts Cancer Registry    
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Table 17. 
FIVE LEADING CANCER MORTALITY RATES BY RACE/ETHNICITY AND SEX 
Massachusetts, 2011-2015 
 
 
MALES 
 
 
AGE-ADJUSTED
1
 MORTALITY RATE
2
 
RANK White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
1 
Bronchus & Lung     
50.0 
Bronchus & Lung     
46.6 
Bronchus & Lung     
35.4 
Bronchus & Lung 
23.3 
2 
Prostate                     
17.9 
Prostate                    
36.3 
Liver & Intrahepatic 
Bile Duct                 
14.4 
Prostate                
15.5 
3 
Colon/Rectum          
15.0 
Colon/Rectum         
16.0 
Colon/Rectum        
9.2 
Liver & Intrahepatic 
Bile Duct                 
12.9 
4 
Pancreas                   
12.7 
Liver & Intrahepatic 
Bile Duct                 
14.5 
Prostate                  
7.2 
Colon/Rectum        
9.9 
5 
Esophagus                  
9.1 
Pancreas                   
12.7 
Pancreas                  
5.7 
Stomach                 
8.1 
 
 
FEMALES 
 
 
AGE-ADJUSTED
1
 MORTALITY RATE
2
 
RANK White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
1 
Bronchus & Lung        
38.5 
Bronchus & Lung        
28.0 
Bronchus & Lung        
18.3 
Bronchus & Lung        
12.0 
2 
Breast                         
18.7 
Breast                        
20.6 
Colon/Rectum             
8.9 
Breast             
10.7 
3 Colon/Rectum           
10.6 
Colon/Rectum          
12.8 
Breast                         
7.6 
Colon/Rectum 
9.0 
4 
Pancreas                    
10.0 
Pancreas                      
9.5 
Pancreas                     
7.6 
Pancreas          
5.0 
5 
Ovary                          
7.8 
Corpus Uteri & Uterus, 
NOS                            
8.6 
Liver & Intrahepatic 
Bile Duct                    
5.3 
Non-Hodgkin 
Lymphoma      
4.5 
 
 
 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
 per 100,000  
 
Source:  Massachusetts Vital Statistics 
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Table 18. 
NUMBER AND PERCENTAGE OF DEATHS FOR SELECTED CANCER SITES BY RACE/ETHNICITY
1
 
Massachusetts, 2011-2015 
MALES 
 
  All Races
2
 White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
Cancer Site / Type Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths 
All Sites 32,392 100.0 29105 100.0 1469 100.0 747 100.0 905 100.0 
Brain & Other Nervous System 945 2.9 873 3.0 28 2.0 13 1.7 25 2.8 
Breast 59 0.2 57 0.2 1 0.1 1 0.1 0 0.0 
Bronchus & Lung 8409 26.0 7657 26.3 345 23.5 210 28.1 166 18.3 
Colon / Rectum 2544 7.8 2278 7.8 129 8.8 60 8.0 63 7.0 
Esophagus 1544 4.8 1444 5.0 45 3.1 23 3.1 23 2.5 
Hodgkin Lymphoma 48 0.2 37 0.1 2 0.1 2 0.3 7 0.8 
Kidney & Renal Pelvis 879 2.7 807 2.8 36 2.5 9 1.2 25 2.8 
Larynx 263 0.8 232 0.8 11 0.7 5 0.7 12 1.3 
Leukemia 1409 4.3 1283 4.4 45 3.1 27 3.6 45 5.0 
Liver & Intrahepatic Bile Ducts 1809 5.6 1416 4.9 137 9.3 132 17.7 112 12.4 
Melanoma of Skin 666 2.1 649 2.2 6 0.4 1 0.1 5 0.5 
Multiple Myeloma 663 2.0 568 2.0 53 3.6 13 1.7 26 2.9 
Non-Hodgkin Lymphoma 1128 3.5 1027 3.5 37 2.5 20 2.7 35 3.9 
Oral Cavity & Pharynx 666 2.1 576 2.0 35 2.4 21 2.8 28 3.1 
Pancreas 2181 6.7 1978 6.8 94 6.4 37 5.0 60 6.6 
Prostate 3005 9.3 2651 9.1 217 14.8 34 4.5 87 9.6 
Stomach 705 2.2 545 1.9 52 3.5 39 5.2 63 7.0 
Testis 24 0.1 23 0.1 0 0.0 0 0.0 1 0.1 
Thyroid 114 0.3 104 0.4 3 0.2 2 0.3 4 0.4 
Urinary Bladder 1318 4.1 1258 4.3 30 2.0 10 1.6 14 1.5 
Other Sites 4013 12.4 3642 12.5 163 11.1 88 11.8 104 11.5 
 
                                                 
1
 Race/ethnicity categories are mutually exclusive.  Deaths are only included in one race/ethnicity category. 
2
 The number of deaths for all races is not the sum of deaths by race/ethnicity. 
 
Source:  Massachusetts Vital Statistics 
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Table 19. 
NUMBER AND PERCENTAGE OF DEATHS FOR SELECTED CANCER SITES BY RACE/ETHNICITY
1
 
Massachusetts, 2011-2015 
FEMALES 
 
  All Races
2
 White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
Cancer Site / Type Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths 
All Sites 31,705 100.0 28,599 100.0 1478 100.0 623 100.0 860 2.7 
Brain & Other Nervous System 757 2.4 692 2.4 21 1.4 20 3.2 23 2.7 
Breast 4178 13.2 3730 13.0 231 15.6 69 11.1 123 14.3 
Bronchus & Lung 8327 26.2 7746 27.1 303 20.5 137 22.0 114 13.3 
Cervix Uteri 253 0.8 195 0.7 26 1.8 7 1.1 21 2.4 
Colon / Rectum 2591 8.2 2286 8.0 142 9.6 66 10.6 85 9.9 
Corpus Uteri & Uterus, NOS 1078 3.4 913 3.2 96 6.5 22 3.5 39 4.5 
Esophagus 382 1.2 350 1.2 12 0.8 7 1.1 11 1.3 
Hodgkin Lymphoma 45 0.1 40 0.1 0 0.0 1 0.2 3 0.3 
Kidney & Renal Pelvis 511 1.6 478 1.7 14 0.9 2 0.3 13 1.5 
Larynx 92 0.3 85 0.3 2 0.1 1 0.2 3 0.3 
Leukemia 1110 3.5 997 3.5 52 3.5 17 2.7 41 4.8 
Liver & Intrahepatic Bile Ducts 809 2.5 675 2.4 44 3.0 43 6.9 43 5.0 
Melanoma of Skin 422 1.3 413 1.4 2 0.1 2 0.3 4 0.5 
Multiple Myeloma 640 2.0 544 1.9 66 4.5 4 0.6 23 2.7 
Non-Hodgkin Lymphoma 1015 3.2 921 3.2 33 2.2 22 3.5 37 4.3 
Oral Cavity & Pharynx 300 0.9 269 0.9 10 0.7 9 1.4 10 1.2 
Ovary 1689 5.3 1552 5.4 74 5.0 26 4.2 29 3.4 
Pancreas 2346 7.4 2125 7.4 103 7.0 55 8.8 53 6.2 
Stomach 534 1.7 419 1.5 42 2.8 33 5.3 36 4.2 
Thyroid 105 0.3 86 0.3 7 0.5 3 0.5 9 1.1 
Urinary Bladder 612 1.9 581 2.0 20 1.4 4 0.6 6 0.7 
Other Sites 3909 12.3 3502 12.2 178 12.0 73 11.7 134 15.6 
 
                                                 
1
 Race/ethnicity categories are mutually exclusive.  Deaths are only included in one race/ethnicity category. 
2
 The number of deaths for all races is not the sum of deaths by race/ethnicity. 
 
 Source: Massachusetts Vital Statistics 
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Table 20. 
NUMBER AND PERCENTAGE OF DEATHS FOR SELECTED CANCER SITES BY RACE/ETHNICITY
1
 
Massachusetts, 2011-2015 
TOTAL 
 
  All Races2 White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
Cancer Site / Type Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths Deaths % of Deaths 
All Sites 64097 100.0 57707 100.0 2947 100.0 1370 110.0 1765 100.0 
Brain & Other Nervous System 1702 2.7 1565 2.7 49 1.7 33 2.4 48 2.7 
Breast 4237 6.6 3790 6.6 232 7.9 70 5.1 123 7.0 
Bronchus & Lung 16736 26.1 15403 26.7 648 22.0 347 25.3 280 15.9 
Cervix Uteri 253 0.4 195 0.3 26 0.9 7 0.5 21 1.2 
Colon / Rectum 5135 8.0 4564 7.9 271 9.2 126 9.2 148 8.4 
Corpus Uteri & Uterus, NOS 1078 1.7 913 1.6 96 3.3 22 1.6 39 2.2 
Esophagus 1926 3.0 1794 3.1 57 1.9 30 2.2 34 1.9 
Hodgkin Lymphoma 93 0.2 77 0.1 2 0.1 3 0.2 10 0.6 
Kidney & Renal Pelvis 1390 2.2 1285 2.2 50 1.7 11 0.8 38 2.2 
Larynx 355 0.6 317 0.5 13 0.4 6 0.4 15 0.9 
Leukemia 2519 3.9 2280 4.0 97 3.3 44 3.2 86 4.9 
Liver & Intrahepatic Bile Ducts 2618 4.1 2091 3.6 181 6.1 175 12.8 155 8.8 
Melanoma of Skin 1088 1.7 1062 1.8 8 0.3 3 0.2 9 0.5 
Multiple Myeloma 1303 2.0 1112 1.9 119 4.1 17 1.2 49 2.8 
Non-Hodgkin Lymphoma 2143 3.3 1948 3.4 70 2.4 42 3.1 72 4.1 
Oral Cavity & Pharynx 966 1.5 845 1.5 45 1.5 30 2.2 38 2.1 
Ovary 1689 2.6 1552 2.7 74 2.5 26 1.9 29 1.6 
Pancreas 4527 7.1 4103 7.1 197 6.7 92 6.7 113 6.4 
Prostate 3005 4.7 2651 4.6 217 7.4 34 2.5 87 4.9 
Stomach 1239 1.9 964 1.7 94 3.2 72 5.3 99 5.6 
Testis 24 0.04 23 0.04 0 0.0 0 0.0 1 0.1 
Thyroid 219 0.3 190 0.3 10 0.3 5 0.4 13 0.7 
Urinary Bladder 1930 3.0 1839 3.2 50 1.7 14 1.0 20 1.0 
Other Sites 7922 12.4 7144 12.4 341 11.5 161 11.7 238 13.5 
 
                                                 
1
 Race/ethnicity categories are mutually exclusive.  Deaths are only included in one race/ethnicity category. 
2
 The number of deaths for all races is not the sum of deaths by race/ethnicity. 
 
Source: Massachusetts Vital Statistics 
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Table 21. 
AGE-ADJUSTED
1
 MORTALITY RATES
2
 AND 95% CONFIDENCE LIMITS (95% CL)  
FOR SELECTED CANCER SITES BY RACE/ETHNICITY
3
 
Massachusetts, 2011-2015 
MALES 
 
  All Races White, non-Hispanics Black, non-Hispanics Asian, non-Hispanics Hispanics 
Cancer Site / Type Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL 
All Sites 186.8 184.8-188.9 190.8 188.6-192.9 198.2 188.1-208.3 119.8 111.2-128.4 122.9 114.9-130.9 
Brain & Other Nervous System 5.3 4.9-5.6 5.7 5.3-6.1 2.6 1.7-3.7 * * 2.4 1.4-3.3 
Breast 0.3 0.2-0.4 0.4 0.3-0.5 * * * * * * 
Bronchus & Lung 48.4 47.4-49.4 50.0 48.9-51.1 46.6 41.7-51.4 35.4 30.6-40.2 23.3 19.8-26.9 
Colon / Rectum 14.7 14.1-15.3 15.0 14.4-15.6 16.0 13.2-18.7 9.2 6.8-11.5 9.9 7.5-12.4 
Esophagus 8.5 8.1-9.0 9.1 8.6-9.6 5.8 4.1-7.5 4.3 2.5-6.1 3.1 1.8-4.3 
Hodgkin Lymphoma 0.3 0.2-0.4 0.3 0.2-0.4 * * * * * * 
Kidney & Renal Pelvis 4.9 4.6-5.3 5.1 4.8-5.5 4.9 3.3-6.5 * * 2.7 1.6-3.7 
Larynx 1.5 1.3-1.6 1.5 1.3-1.7 * * * * * * 
Leukemia 8.5 8.0-8.9 8.8 8.3-9.2 6.4 4.5-8.2 4.2 2.6-5.8 5.6 4.0-7.2 
Liver & Intrahepatic Bile Ducts 9.7 9.3-10.2 8.7 8.3-9.2 14.5 12.1-16.9 19.5 16.2-22.9 12.9 10.5-15.3 
Melanoma of Skin 3.8 3.6-4.1 4.3 4.0-4.6 * * * * * * 
Multiple Myeloma 3.9 3.6-4.2 3.8 3.5-4.1 7.4 5.4-9.4 * * 4.3 2.6-5.9 
Non-Hodgkin Lymphoma 6.7 6.3-7.1 6.9 6.5-7.3 4.9 3.3-6.4 3.0 1.7-4.4 4.5 3.0-6.0 
Oral Cavity & Pharynx 3.6 3.3-3.9 3.6 3.3-3.9 4.2 2.8-5.6 2.9 1.7-4.2 3.7 2.3-5.1 
Pancreas 12.3 11.8-12.9 12.7 12.2-13.3 12.7 10.1-15.3 5.7 3.9-7.6 7.4 5.5-9.3 
Prostate 18.2 17.6-18.9 17.9 17.2-18.6 36.3 31.5-41.2 7.2 4.8-9.6 15.5 12.3-18.8 
Stomach 4.1 3.8-4.4 3.6 3.3-3.9 7.3 5.4-9.4 5.6 3.9-7.4 8.1 6.1-10.1 
Testis 0.1 0.1-0.2 0.2 0.1-0.2 * * * * * * 
Thyroid 0.6 0.5-0.8 0.7 0.5-0.8 * * * * * * 
Urinary Bladder 7.9 7.4-8.3 8.4 7.9-8.9 4.8 3.1-6.6 * * * * 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population.   
2
 per 100,000     
3
 Race/ethnicity categories are mutually exclusive. Deaths are only included in one race/ethnicity category. 
*An age-adjusted mortality rate was not calculated when there were fewer than 20 deaths. 
 
Source: Massachusetts Vital Statistics 
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Table 22. 
AGE-ADJUSTED
1
 MORTALITY RATES
2
 AND 95% CONFIDENCE LIMITS (95% CL) 
FOR SELECTED CANCER SITES BY RACE/ETHNICITY
3
 
Massachusetts, 2011-2015 
FEMALES 
 
  All Races White, non-Hispanics Black, non-Hispanics Asian, non-Hispanics Hispanics 
Cancer Site / Type Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL 
All Sites 135.2 133.7-136.7 139.3 137.6-140.9 134.9 128.0-141.7 79.4 73.2-85.6 86.2 80.4-91.9 
Brain & Other Nervous System 3.5 3.2-3.7 3.8 3.5-4.0 * * 2.2 1.2-3.1 2.1 1.2-2.9 
Breast 18.1 17.6-18.7 18.7 18.1-19.2 20.6 18.0-23.3 7.6 5.8-9.4 10.7 8.8-12.6 
Bronchus & Lung 36.2 35.4-37.0 38.5 37.6-39.4 28.0 27.8-31.1 18.3 15.2-21.3 12.0 9.8-14.2 
Cervix Uteri 1.2 1.0-1.3 1.1 1.0-1.3 2.2 1.3-3.0 * * 1.9 1.1-2.7 
Colon / Rectum 10.6 10.2-11.0 10.6 10.2-11.0 12.8 10.7-14.9 8.9 6.7-11.0 9.1 7.1-11.0 
Corpus Uteri & Uterus, NOS 4.6 4.3-4.8 4.4 4.1-4.7 8.6 6.9-10.4 2.6 1.5-3.7 3.9 2.7-5.2 
Esophagus 1.6 1.4-1.8 1.7 1.5-1.8 * * * * * * 
Hodgkin Lymphoma 0.2 0.1-0.3 0.2 0.1-0.3 * * * * * * 
Kidney & Renal Pelvis 2.1 1.9-2.3 2.2 2.0-2.4 * * * * * * 
Larynx 0.4 0.3-0.5 0.4 0.3-0.5 * * * * * * 
Leukemia 4.7 4.5-5.0 4.8 4.5-5.1 5.0 3.6-6.3 * * 3.9 2.7-5.1 
Liver & Intrahepatic Bile Ducts 3.4 3.2-3.7 3.3 3.0-3.5 4.0 2.8-5.2 5.3 3.7-6.9 4.3 3.0-5.6 
Melanoma of Skin 1.8 1.6-2.0 2.1 1.9-2.3 * * * * * * 
Multiple Myeloma 2.6 2.4-2.8 2.5 2.3-2.7 6.2 4.7-7.7 * * 2.5 1.5-3.5 
Non-Hodgkin Lymphoma 4.2 3.9-4.4 4.3 4.0-4.5 3.0 2.0-4.1 3.1 1.8-4.4 4.5 3.0-5.9 
Oral Cavity & Pharynx 1.2 1.1-1.4 1.2 1.1-1.4 * * * * * * 
Ovary 7.3 7.0-7.7 7.8 7.4-8.2 6.4 5.0-7.9 3.1 1.9-4.2 2.6 1.7-3.6 
Pancreas 9.8 9.4-10.1 10.0 9.6-10.5 9.5 7.6-11.3 7.6 5.6-9.7 5.0 3.7-6.4 
Stomach 2.3 2.1-2.5 2.0 1.8-2.2 4.0 2.8-5.2 4.0 2.6-5.4 3.3 2.2-4.4 
Thyroid 0.4 0.3-0.5 0.4 0.3-0.5 * * * * * * 
Urinary Bladder 2.4 2.2-2.6 2.6 2.4-2.8 * * * * * * 
 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
 per 100,000 
3
 Race/ethnicity categories are mutually exclusive. Deaths are only included in one race/ethnicity category. 
* An age-adjusted mortality rate was not calculated when there were fewer than 20 deaths. 
 
Source: Massachusetts Vital Statistics 
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Table 23. 
AGE-ADJUSTED
1
 MORTALITY RATES
2
 AND 95% CONFIDENCE LIMITS (95% CL)  
FOR SELECTED CANCER SITES BY RACE/ETHNICITY
3
 
Massachusetts, 2011-2015 
TOTAL 
  All Races White, non-Hispanics Black, non-Hispanics Asian, non-Hispanics Hispanics 
Cancer Site / Type Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL Rates 95% CL 
All Sites 156.1 154.8-157.3 160.1 158.8-161.4 158.2 152.5-163.9 97.3 92.1-102.4 101.4 96.6-106.1 
Brain & Other Nervous System 4.3 4.1-4.5 4.6 4.4-4.9 2.3 1.6-3.0 1.8 1.2-2.5 2.2 1.6-2.9 
Breast - - - - - - - - - - 
Bronchus & Lung 41.2 40.6-41.8 43.2 42.5-43.9 35.2 32.5-37.9 25.8 23.1-28.6 16.8 14.8-18.8 
Cervix Uteri - - - - - - - - - - 
Colon / Rectum 12.4 12.0-12.7 12.5 12.1-12.9 14.2 12.5-15.9 9.1 7.5-10.6 9.3 7.8-10.9 
Corpus Uteri & Uterus, NOS - - - - - - - - - - 
Esophagus 4.6 4.4-4.8 5.0 4.7-5.2 2.9 2.2-3.7 2.4 1.5-3.3 2.0 1.3-2.7 
Hodgkin Lymphoma 0.2 0.2-0.3 0.2 0.2-0.3 * * * * * * 
Kidney & Renal Pelvis 3.3 3.2-3.5 3.5 3.3-3.7 2.6 1.9-3.3 * * 1.9 1.3-2.5 
Larynx 0.9 0.8-0.9 0.9 0.8-1.0 * * * * * * 
Leukemia 6.3 6.0-6.5 6.5 6.2-6.7 5.3 4.3-6.4 3.1 2.1-4.0 4.6 3.6-5.6 
Liver & Intrahepatic Bile Ducts 6.3 6.0-6.5 5.7 5.5-6.0 8.7 7.4-10.0 11.8 10.0-13.5 8.0 6.8-9.3 
Melanoma of Skin 2.7 2.5-2.8 3.0 2.8-3.2 * * * * * * 
Multiple Myeloma 3.1 3.0-3.3 3.0 2.8-3.2 6.7 5.5-7.9 * * 3.2 2.3-4.1 
Non-Hodgkin Lymphoma 5.2 5.0-5.5 5.4 5.1-5.6 3.8 2.9-4.7 3.1 2.1-4.0 4.5 3.5-5.6 
Oral Cavity & Pharynx 2.3 2.2-2.5 2.3 2.2-2.5 2.3 1.6-2.9 1.9 1.2-2.6 2.2 1.5-2.9 
Ovary - - - - - - - - - - 
Pancreas 10.9 10.6-11.2 11.3 10.9-11.6 11.0 9.4-12.5 6.8 5.4-8.2 6.0 4.9-7.1 
Prostate - - - - - - - - - - 
Stomach 3.0 2.9-3.2 2.7 2.5-2.8 5.3 4.2-6.4 4.8 3.7-5.9 5.3 4.3-6.4 
Testis - - - - - - - - - - 
Thyroid 0.5 0.5-0.6 0.5 0.4-0.6 * * * * * * 
Urinary Bladder 4.6 4.4-4.8 4.9 4.7-5.1 2.9 2.1-3.8 * * 1.3 0.7-1.8 
                                                 
1
 Rates are age-adjusted to the 2000 U.S. Standard Population.   
2
 per 100,000 
3
 Race/ethnicity categories are mutually exclusive.  Deaths are only included in one race/ethnicity category. 
4
Dashes indicate cancers found in only one sex or predominantly in one sex (breast cancer).   
* An age-adjusted mortality rate was not calculated when there were fewer than 20 deaths. 
Source: Massachusetts Vital Statistics 
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Table 24. 
   INCIDENCE RATES
1
 FOR SELECTED CANCER SITES BY SEX 
 Massachusetts (2011-2015) and U.S. (2010-2014)  
 
 MALES FEMALES 
Cancer Site / Type Massachusetts United States Massachusetts United States 
 Rate 95% CL  Rate 95% CL Rate 95% CL Rate 95% CL 
All Sites 493.9* 490.6-497.3 502.0 501.5-502.6 450.9* 448.0-453.8 418.0 417.6-418.4 
Brain & Other Nervous System 7.9 7.4-8.3 7.7 7.7-7.8 6.0 5.6-6.3 5.6 5.5-5.6 
Breast 1.4 1.2-1.6 1.3 1.3-1.3 137.6* 136.0-139.3 123.6 123.4-123.8 
Breast in situ
2
 0.2 0.1-0.2 N/A N/A 41.4* 40.5-42.3 30.6 30.5-30.7 
Bronchus & Lung 69.3* 68.0-70.6 73.0 72.8-73.2 60.2* 59.1-61.2 52.8 52.6-52.9 
Cervix Uteri -- -- -- -- 5.1* 4.8-5.5 7.6 7.5-7.6 
Colon / Rectum 41.8* 40.9-42.8 45.9 45.7-46.0 33.1* 32.3-33.9 34.8 34.7-35.0 
Corpus Uteri & Uterus, NOS -- -- -- -- 29.4* 28.7-30.1 25.9 25.8-26.0 
Esophagus 9.7* 9.2-10.1 8.0 7.9-8.0 2.2* 2.0-2.4 1.8 1.8-1.8 
Hodgkin Lymphoma 3.2 3.0-3.5 3.0 3.0-3.1 2.6 2.4-2.9 2.4 2.3-2.4 
Kidney & Renal Pelvis 22.4 21.7-23.1 21.8 21.7-21.9 10.8 10.3-11.2 11.3 11.2-11.4 
Larynx 5.5* 5.2-5.9 6.0 6.0-6.1 1.4 1.3-1.6 1.4 1.3-1.4 
Leukemia 16.5* 15.9-17.1 17.6 17.5-17.7 9.9* 9.4-10.3 10.7 10.6-10.8 
Liver & Intrahepatic Bile Ducts 12.9* 12.4-13.4 12.1 12.0-12.2 3.8* 3.5-4.0 4.2 4.1-4.2 
Melanoma of Skin 24.8* 24.0-25.6 26.6 26.4-26.7 16.8 16.2-17.3 16.3 16.2-16.4 
Multiple Myeloma 8.1 7.7-8.5 8.1 8.0-8.2 5.3 5.0-5.6 5.3 5.3-5.4 
Non-Hodgkin Lymphoma 23.4 22.6-24.1 22.9 22.8-23.0 16.3 15.8-16.9 15.8 15.7-15.8 
Oral Cavity & Pharynx 17.8 17.2-18.4 17.4 17.3-17.5 7.1* 6.8-7.5 6.4 6.3-6.4 
Ovary -- -- -- -- 11.6 11.1-12.1 11.4 11.4-11.5 
Pancreas 14.5 13.9-15.1 14.2 14.2-14.3 11.5 11.1-12.0 11.1 11.0-11.1 
Prostate 106.3* 104.8-107.8 115.0 114.8-115.2 -- -- -- -- 
Stomach 9.3 8.9-9.8 9.2 9.1-9.3 4.7 4.4-5.0 4.6 4.6-4.7 
Testis 6.5* 6.1-6.9 5.5 5.5-5.6 -- -- -- -- 
Thyroid 10.6* 10.2-11.1 7.2 7.1-7.2 29.6* 28.7-30.4 21.1 21.0-21.2 
Urinary Bladder 40.4* 39.4-41.4 35.8 35.7-36.0 11.2* 10.8-11.7 8.8 8.8-8.9 
 
 
 
 
 
 
 
 
 
 
 
___________________________________________________ 
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2
Breast in situ cases are excluded from “All Sites” and from breast cancer counts. 
N/A – not available 
* indicates that the Massachusetts incidence rate differed significantly from the national rate (p < 0.05). 
 Data Sources:  Massachusetts: Massachusetts Cancer Registry and United States: NAACCR Fast Stats: An interactive 
tool for quick access to key NAACCR cancer statistics.  North American Association of Central Cancer Registries.  
http://www.naaccr.org/. (Accessed on 1-12-2018) 
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Table 25. 
MORTALITY RATES
1 
FOR SELECTED CANCER SITES BY SEX 
Massachusetts and U.S. (2011-2015)
 
 
 MALES FEMALES 
Cancer Site / Type Massachusetts United States Massachusetts United States 
 Rate 95% CL Rate 95% CL Rate 95% CL Rate 95% CL 
All Sites 186.8* 184.8-188.9 196.3 196.0-196.6 135.2* 133.7-136.7 139.8 139.6-140.1 
Brain & Other Nervous System 5.3 4.9-5.6 5.3 5.3-5.4 3.5 3.2-3.7 3.6 3.5-3.6 
Breast 0.3 0.2-0.4 0.3 0.3-0.3 18.1* 17.6-18.7 20.9 20.8-21.0 
Bronchus & Lung 48.4* 47.4-49.4 53.6 53.5-53.8 36.2 35.4-37.0 35.4 35.3-35.5 
Cervix Uteri - - - - 1.2* 1.0-1.3 2.3 2.3-2.3 
Colon / Rectum 14.7* 14.1-15.3 17.4 17.3-17.5 10.6* 10.2-11.0 12.4 12.4-12.5 
Corpus Uteri & Uterus, NOS - - - - 4.6 4.3-4.8 4.6 4.6-4.7 
Esophagus 8.5* 8.1-9.0 7.2 7.1-7.3 1.6 1.4-1.8 1.5 1.5-1.5 
Hodgkin Lymphoma 0.3 0.2-0.4 0.4 0.4-0.4 0.2 0.1-0.2 0.3 0.2-0.3 
Kidney & Renal Pelvis 4.9* 4.6-5.3 5.6 5.6-5.7 2.1* 1.9-2.3 2.4 2.4-22.5 
Larynx 1.5* 1.3-1.6 1.8 1.8-1.8 0.4 0.3-0.5 0.4 0.3-0.4 
Leukemia 8.5 8.0-8.9 8.9 8.8-8.9 4.7 4.5-5.0 4.9 4.9-5.0 
Liver & Intrahepatic Bile Ducts 9.7 9.3-10.2 9.5 9.4-9.5 3.4* 3.2-3.7 3.8 3.8-3.9 
Melanoma of Skin 3.8 3.6-4.1 3.9 3.8-3.9 1.8 1.6-2.0 1.6 1.6-1.7 
Multiple Myeloma 3.9* 3.6-4.2 4.3 4.3-4.4 2.6 2.4-2.8 2.8 2.7-2.8 
Non-Hodgkin Lymphoma 6.7* 6.3-7.1 7.4 7.3-7.5 4.2 3.9-4.4 4.5 4.4-4.5 
Oral Cavity & Pharynx 3.6 3.3-3.9 3.9 3.8-3.9 1.2 1.1-1.4 1.3 1.3-1.3 
Ovary - - - - 7.3 7.0-7.7 7.2 7.1-7.2 
Pancreas 12.3 11.8-12.9 12.6 12.5-12.6 9.8 9.4-10.1 9.5 9.5-9.6 
Prostate 18.2* 17.6-18.9 19.4 19.3-19.5 - - - - 
Stomach 4.1 3.8-4.4 4.3 4.2-4.3 2.3 2.1-2.5 2.3 2.3-2.3 
Testis 0.1 0.1-0.2 0.2 0.2-0.2 - - - - 
Thyroid 0.6 0.5-0.8 0.5 0.5-0.5 0.4 0.3-0.5 0.5 0.5-0.5 
Urinary Bladder 7.9 7.4-8.3 7.5 7.5-7.6 2.4 2.2-2.6 2.1 2.1-2.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
__________________________________________________ 
 Rates are age-adjusted to the 2000 U.S. Standard Population. 
2Breast in situ cases are excluded from “All Sites” and from breast cancer counts. 
N/A – not applicable 
* indicates that the Massachusetts mortality rate differed significantly from the national rate (p < 0.05). 
 Data Sources:  Massachusetts: Massachusetts Vital Statistics and United States:  National Center for Health Statistics. 
 
 45 
 
 
 
 
 
 
 
 
 
APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 46 
 
APPENDIX I 
ICD CODES USED FOR THIS REPORT  
Cancer Site/Type .……….C o d e s……….. 
 ICD-O-3* ICD-10** 
Brain & Other  
Nervous System 
C70.0-C72.9 
except 9050-9055, 9140,  
9590-9992 
 
C70-C72 
Breast 
 (includes in situ) 
C50.0 – C50.9 
except 9050-9055, 9140,  
9590-9992 
 
C50 
Bronchus & Lung C34.0 – C34.9  
except 9050-9055, 9140,  
9590-9992 
 
C34 
Cervix Uteri C53.0 – C53.9 
except 9050-9055, 9140,  
9590-9992 
 
C53 
Colon/ Rectum C18.0-C18.9, 
C19.9, C20.9, 
C26.0 
except 9050-9055, 9140,  
9590-9992 
 
C18 – C20, C26.0 
Corpus Uteri  
& Uterus, NOS 
C54.0 – C54.9, 
C55.9 
except 9050-9055, 9140,  
9590-9992 
 
C54 – C55 
Esophagus C15.0-C15.9 
except 9050-9055, 9140,  
9590-9992 
 
C15 
Hodgkin Lymphoma C00.00 – C80.9  
(includes 9650-9667) 
 
C81 
Kidney &  
Renal Pelvis 
C64.9, C65.9 
except 9050-9055, 9140,  
9590-9992 
C64- C65 
Larynx C32.0 – C32.9 
except 9050-9055, 9140,  
9590-9992 
C32 
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Leukemia 
 
 
 
 
 
 
 
 
 
C00.0 – C80.9 
(includes 9733, 9742, 
9800-9801, 9805-9809, 9820, 
9826, 9831-9836, 9840, 9860-
9861, 9863, 9865-9867, 9869-
9876, 9891, 9895-9898, 9910-
9911, 9920, 9930-9931, 9940, 
9945-9946, 9948, 9963-9964) 
 
C42.0, C42.1, C42.4 
(includes 9811-9818, 9823, 9827, 
9837) 
 
C90.1, C91 – C95 
Liver and Intrahepatic 
Bile Ducts 
C22.0, C22.1 
except 9050-9055, 9140,  
9590-9992 
C22 
Melanoma of Skin C44.0 – C44.9 
(includes 8720-8790) 
C43 
Multiple Myeloma C00.0-C80.9 
(includes 9731, 9732, 
9734) 
 
C90.0, C90.2 
Non – Hodgkin  
Lymphoma 
C02.4, C098, C099, C111, 
C142, C379, C422, C770-
C779 (includes 9590-9597, 
9670-9671, 9673, 9675, 9678-
9680, 9684, 9687-9691, 9695, 
9698-9702, 9705, 9708-9709, 
9712, 9714-9719, 9724-9729, 
9735, 9737-9738, 9811-9818, 
9823, 9827, 9837) 
 
All sites except C02.4, C90.8-
C09.9, C11.1, C14.2, C37.9, 
C42.2, C77.0-C77.9 (includes  
9590-9597, 9670-9671, 9673, 
9675, 9678-9680, 9684, 9687, 
9688, 9689-9691, 9695, 9698-
9702, 9705, 9708-9709, 9712, 
9714-9719, 9724-9729, 9735, 
9737, 9738) 
 
All sites except C02.4, c09.8-
C09.9, C11.1, C14.2, C37.9, 
C42.0-C42.2, c42.4, C77.0-
C77.9 (includes 9811-9818, 
9823, 9827, 9837) 
C82 – C85, C96.3 
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Oral Cavity  
& Pharynx 
C00.0 – C14.8 
except 9050-9055, 9140,  
9590-9992 
 
C00 – C14 
Ovary C56.9 
except 9050-9055, 9140,  
9590-9992 
 
C56 
Pancreas C25.0 – C25.9 
except 9050-9055, 9140,  
9590-9992 
 
 
Prostate 
 
 
C61.9 
except 9050-9055, 9140,  
9590-9992 
C61 
Stomach 
 
C16.0 – C16.9 
except 9050-9055, 9140,  
9590-9992 
 
C16 
Testis C62.0 – C62.9 
except 9050-9055, 9140,  
9590-9992 
 
C62 
Thyroid C73.9 
except 9050-9055, 9140,  
9590-9992 
 
C73 
Urinary Bladder 
(includes in situ) 
C67.0 – C67.9 
except 9050-9055, 9140,  
9590-9992 
 
C67 
 
 
* International Classification of Diseases for Oncology, 3d Ed. (includes codes added since 
publication) for incidence data 
** International Classification of Diseases, Tenth Revision (includes codes added since publication) 
for mortality data 
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APPENDIX II: 
 
Population and Rate Changes 
 
The population estimates for 2011-2015 used in this report were produced by the National Center for 
Health Statistics (NCHS) in collaboration with the U.S. Census Bureau’s Population Estimation Program.  
The NCHS takes the Census Bureau population estimates file and reallocates the multiple race categories 
required by the 1997 Office of Management and Budget (OMB) specifications back into the four race 
categories specified in the 1977 OMB specifications so that the estimates will be compatible with previous 
years’ populations. (3)  The estimates are divided into mutually exclusive racial/ethnic categories similar to 
those of the MCR. 
 
Please note that the statewide age-adjusted rates published in this report cannot be compared with those 
published in reports prior to July 2007, because the overall population count and the age distribution of the 
population, which were based on the Census 2000 count, differ. 
 
The difference in the new population estimates is pronounced for Hispanics and black, non-Hispanics.  The 
Hispanic and black, non-Hispanic populations have increased 15% since 2000, while the overall state 
population has increased by 1%.  It is important to remember that both age-adjusted cancer incidence and 
cancer death rates are not a measure of the actual risk of cancer or of death from it.  Rather, age-adjusted 
rates are summary measures used to compare cancer incidence and mortality trends over time or among 
different populations whose age distributions differ.  For specific examples of the effect of new population 
estimates on age-adjusted rates, see Appendix II in the report Cancer Incidence and Mortality in 
Massachusetts 2000-2004: Statewide Report, available at 
http://www.mass.gov/eohhs/docs/dph/cancer/state/registry-statewide-00-04-report.pdf 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.
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Appendix III 
    
POPULATION ESTIMATES BY AGE, RACE/ETHNICTIY, AND SEX  
Massachusetts, 2011-2015 
 
 White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Hispanic 
Age 
Group 
Males   Females Total Males Females Total Males Females Total Males Females Total 
00-04 599582 572123 1171705 89827 84540 174367 69502 67869 137371 174587 166763 1829371 
05-09 647533 618894 1266427 89285 84545 173830 68095 67552 135647 160176 154452 1895246 
10-14 712339 679236 1391575 88149 84700 172849 62596 63726 126322 151779 146428 1993985 
15-19 818320 800816 1619136 100453 98611 199064 70209 76924 147133 164804 157439 2293446 
20-24 832986 834697 1667683 109635 107192 216827 90551 97938 188489 175779 166330 2421587 
25-29 820012 825186 1645198 93392 94324 187716 99234 111954 211188 160076 152239 2362075 
30-34 749333 759781 1509114 82815 88511 171326 94803 106739 201542 150186 147639 2184539 
35-39 694231 713345 1407576 76803 83213 160016 86589 95411 182000 128862 133550 2015969 
40-44 808466 842405 1650871 76304 83508 159812 81411 87656 169067 112245 121365 2218312 
45-49 938105 975726 1913831 78866 84123 162989 67390 72734 140124 100361 110546 2433631 
50-54 1019746 1064497 2084243 75759 81341 157100 56875 61950 118825 82382 93083 2541852 
55-59 956796 1014650 1971446 62403 69649 132052 46583 52775 99358 61788 72103 2342225 
60-64 823817 896351 1720168 46705 54976 101681 37077 42678 79755 43954 53257 2002942 
65-69 647698 726488 1374186 31740 40768 72508 25370 29383 54753 29601 38432 1572338 
70-74 438022 523693 961715 20329 29264 49593 18884 21646 40530 18782 25836 1098389 
75-79 313303 410083 723386 13806 22188 35994 13580 15533 29113 11642 17619 819176 
80-84 240271 364116 604387 8543 15842 24385 8095 10333 18428 6808 11451 666426 
85+ 229216 489437 718653 7043 16512 23555 5936 9300 15236 5749 10680 774825 
 
 
 
Population Data Source: United States Census Data (2011-2015) 
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Appendix IV 
Racial/Ethnic Breakdown of the Massachusetts and United States Populations* 
  
     
      Massachusetts (2011-2015) 
 
White, NH
74.3%
Other*
2.7%Hispanic
10.6%
Asian, NH
5.9%
Black, NH
6.5%
 
      United States (2011-2015) 
 
White, NH
62.3%
Black, NH
12.3%
Asian, NH
5.1%
Hispanic
17.1%
Other*
3.2%
        
 
Data Source: United States Census Data, American Community Survery, 2011-2015 
*Other includes people reporting 2 or more races. 
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